BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature. 2006;444:1083-1087. [PMID: 17183323 DOI: 10.1038/nature05313] [Cited by in Crossref: 707] [Cited by in F6Publishing: 655] [Article Influence: 47.1] [Reference Citation Analysis]
Number Citing Articles
1 Mancuso MR, Kuhnert F, Kuo CJ. Developmental angiogenesis of the central nervous system. Lymphat Res Biol 2008;6:173-80. [PMID: 19093790 DOI: 10.1089/lrb.2008.1014] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
2 Stricker TP, Kumar V. Neoplasia. Robbins and Cotran Pathologic Basis of Disease. Elsevier; 2010. pp. 259-330. [DOI: 10.1016/b978-1-4377-0792-2.50012-2] [Cited by in Crossref: 25] [Article Influence: 2.1] [Reference Citation Analysis]
3 Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol. 2011;12:551-564. [PMID: 21860391 DOI: 10.1038/nrm3176] [Cited by in Crossref: 601] [Cited by in F6Publishing: 542] [Article Influence: 54.6] [Reference Citation Analysis]
4 Liu X, Luo Q, Zheng Y, Liu X, Hu Y, Liu W, Luo M, Zhao Y, Zou L. NOTCH4 signaling controls EFNB2-induced endothelial progenitor cell dysfunction in preeclampsia. Reproduction. 2016;152:47-55. [PMID: 27069008 DOI: 10.1530/rep-16-0132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Akiyama J, Okamoto R, Iwasaki M, Zheng X, Yui S, Tsuchiya K, Nakamura T, Watanabe M. Delta-like 1 expression promotes goblet cell differentiation in Notch-inactivated human colonic epithelial cells. Biochem Biophys Res Commun 2010;393:662-7. [PMID: 20170633 DOI: 10.1016/j.bbrc.2010.02.048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
6 Han J, Shen Q. Targeting γ-secretase in breast cancer. Breast Cancer (Dove Med Press). 2012;4:83-90. [PMID: 24367196 DOI: 10.2147/bctt.s26437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
7 Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, Pourreyron C, Cassidy AJ, Deangelo DJ, Weinstock DM, Krop IE, Dillon D, Brock JE, Lazar AJ, Peto M, Cho RJ, Stoeck A, Haines BB, Sathayanrayanan S, Rodig S, Aster JC. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. PLoS One 2013;8:e67306. [PMID: 23825651 DOI: 10.1371/journal.pone.0067306] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
8 Rizzo P, Miele L, Ferrari R. The Notch pathway: a crossroad between the life and death of the endothelium. Eur Heart J. 2013;34:2504-2509. [PMID: 22645188 DOI: 10.1093/eurheartj/ehs141] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
9 Angara K, Borin TF, Arbab AS. Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma. Transl Oncol 2017;10:650-60. [PMID: 28668763 DOI: 10.1016/j.tranon.2017.04.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 11.0] [Reference Citation Analysis]
10 Jubb AM, Turley H, Moeller HC, Steers G, Han C, Li JL, Leek R, Tan EY, Singh B, Mortensen NJ. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. Br J Cancer. 2009;101:1749-1757. [PMID: 19844231 DOI: 10.1038/sj.bjc.6605368] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.0] [Reference Citation Analysis]
11 Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134:2709-2718. [PMID: 17611219 DOI: 10.1242/dev.004184] [Cited by in Crossref: 289] [Cited by in F6Publishing: 278] [Article Influence: 19.3] [Reference Citation Analysis]
12 Porcheri C, Golan O, Calero-Nieto FJ, Thambyrajah R, Ruiz-Herguido C, Wang X, Catto F, Guillén Y, Sinha R, González J, Kinston SJ, Mariani SA, Maglitto A, Vink CS, Dzierzak E, Charbord P, Göttgens B, Espinosa L, Sprinzak D, Bigas A. Notch ligand Dll4 impairs cell recruitment to aortic clusters and limits blood stem cell generation. EMBO J 2020;39:e104270. [PMID: 32149421 DOI: 10.15252/embj.2019104270] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
13 García-Pascual CM, Ferrero H, Zimmermann RC, Simón C, Pellicer A, Gómez R. Inhibition of Delta-like 4 mediated signaling induces abortion in mice due to deregulation of decidual angiogenesis. Placenta 2014;35:501-8. [PMID: 24780197 DOI: 10.1016/j.placenta.2014.03.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
14 Red-Horse K, Crawford Y, Shojaei F, Ferrara N. Endothelium-microenvironment interactions in the developing embryo and in the adult. Dev Cell. 2007;12:181-194. [PMID: 17276337 DOI: 10.1016/j.devcel.2007.01.013] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 5.9] [Reference Citation Analysis]
15 Wiśniewska W, Kopka M, Siemiątkowska K, Fudalej MM, Sobiborowicz A, Badowska-Kozakiewicz AM. The complexity of tumour angiogenesis based on recently described molecules. Contemp Oncol (Pozn) 2021;25:33-44. [PMID: 33911980 DOI: 10.5114/wo.2021.105075] [Reference Citation Analysis]
16 Deng J, Liu X, Rong L, Ni C, Li X, Yang W, Lu Y, Yan X, Qin C, Zhang L, Qin Z. IFNγ-responsiveness of endothelial cells leads to efficient angiostasis in tumours involving down-regulation of Dll4: IFNγ suppresses the Dll4/Notch pathway in ECs. J Pathol 2014;233:170-82. [DOI: 10.1002/path.4340] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
17 Hermann DM, ElAli A. The abluminal endothelial membrane in neurovascular remodeling in health and disease. Sci Signal 2012;5:re4. [PMID: 22871611 DOI: 10.1126/scisignal.2002886] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
18 Funahashi Y, Hernandez SL, Das I, Ahn A, Huang J, Vorontchikhina M, Sharma A, Kanamaru E, Borisenko V, Desilva DM, Suzuki A, Wang X, Shawber CJ, Kandel JJ, Yamashiro DJ, Kitajewski J. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res. 2008;68:4727-4735. [PMID: 18559519 DOI: 10.1158/0008-5472.can-07-6499] [Cited by in Crossref: 114] [Cited by in F6Publishing: 74] [Article Influence: 8.1] [Reference Citation Analysis]
19 Pinto MP, Sotomayor P, Carrasco-Avino G, Corvalan AH, Owen GI. Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells. Int J Mol Sci 2016;17:E1489. [PMID: 27608016 DOI: 10.3390/ijms17091489] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
20 Stoyanova T, Riedinger M, Lin S, Faltermeier CM, Smith BA, Zhang KX, Going CC, Goldstein AS, Lee JK, Drake JM, Rice MA, Hsu EC, Nowroozizadeh B, Castor B, Orellana SY, Blum SM, Cheng D, Pienta KJ, Reiter RE, Pitteri SJ, Huang J, Witte ON. Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. Proc Natl Acad Sci U S A 2016;113:E6457-66. [PMID: 27694579 DOI: 10.1073/pnas.1614529113] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
21 Zhang H, Wei T, Johnson A, Sun R, Richter G, Strub GM. NOTCH pathway activation in infantile hemangiomas. J Vasc Surg Venous Lymphat Disord 2021;9:489-96. [PMID: 32763337 DOI: 10.1016/j.jvsv.2020.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Singh NK, Kotla S, Kumar R, Rao GN. Cyclic AMP Response Element Binding Protein Mediates Pathological Retinal Neovascularization via Modulating DLL4-NOTCH1 Signaling. EBioMedicine 2015;2:1767-84. [PMID: 26870802 DOI: 10.1016/j.ebiom.2015.09.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
23 Greenberg S, Rugo HS. Triple-negative breast cancer: role of antiangiogenic agents. Cancer J 2010;16:33-8. [PMID: 20164688 DOI: 10.1097/PPO.0b013e3181d38514] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
24 Seftor RE, Hess AR, Seftor EA, Kirschmann DA, Hardy KM, Margaryan NV, Hendrix MJ. Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol 2012;181:1115-25. [PMID: 22944600 DOI: 10.1016/j.ajpath.2012.07.013] [Cited by in Crossref: 193] [Cited by in F6Publishing: 179] [Article Influence: 19.3] [Reference Citation Analysis]
25 Ebens CL, Maillard I. Notch signaling in hematopoietic cell transplantation and T cell alloimmunity. Blood Rev 2013;27:269-77. [PMID: 24050990 DOI: 10.1016/j.blre.2013.08.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
26 Wälchli T, Mateos JM, Weinman O, Babic D, Regli L, Hoerstrup SP, Gerhardt H, Schwab ME, Vogel J. Quantitative assessment of angiogenesis, perfused blood vessels and endothelial tip cells in the postnatal mouse brain. Nat Protoc 2015;10:53-74. [PMID: 25502884 DOI: 10.1038/nprot.2015.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 8.3] [Reference Citation Analysis]
27 Harrington LS, Sainson RC, Williams CK, Taylor JM, Shi W, Li J, Harris AL. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvascular Research 2008;75:144-54. [DOI: 10.1016/j.mvr.2007.06.006] [Cited by in Crossref: 142] [Cited by in F6Publishing: 140] [Article Influence: 10.1] [Reference Citation Analysis]
28 Lehal R, Zaric J, Vigolo M, Urech C, Frismantas V, Zangger N, Cao L, Berger A, Chicote I, Loubéry S, Choi SH, Koch U, Blacklow SC, Palmer HG, Bornhauser B, González-Gaitán M, Arsenijevic Y, Zoete V, Aster JC, Bourquin JP, Radtke F. Pharmacological disruption of the Notch transcription factor complex. Proc Natl Acad Sci U S A 2020;117:16292-301. [PMID: 32601208 DOI: 10.1073/pnas.1922606117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
29 Guilmeau S. Notch signaling and intestinal cancer. Adv Exp Med Biol 2012;727:272-88. [PMID: 22399355 DOI: 10.1007/978-1-4614-0899-4_21] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
30 Aithal MGS, Rajeswari N. Bacoside A Induced Sub-G0 Arrest and Early Apoptosis in Human Glioblastoma Cell Line U-87 MG through Notch Signaling Pathway. Brain Tumor Res Treat 2019;7:25-32. [PMID: 31062528 DOI: 10.14791/btrt.2019.7.e21] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
31 Arima S, Nishiyama K, Ko T, Arima Y, Hakozaki Y, Sugihara K, Koseki H, Uchijima Y, Kurihara Y, Kurihara H. Angiogenic morphogenesis driven by dynamic and heterogeneous collective endothelial cell movement. Development 2011;138:4763-76. [DOI: 10.1242/dev.068023] [Cited by in Crossref: 122] [Cited by in F6Publishing: 116] [Article Influence: 11.1] [Reference Citation Analysis]
32 Zheng Y, Hao Z, Ding Y, Wang Q, Li S, Xiao G, Luo H, Shi Q, Tong S. Expression of delta-like 4 (Drosophila) and vascular endothelial growth factor A in colon cancer and association with tumour angiogenesis. J Int Med Res 2015;43:535-43. [PMID: 26111775 DOI: 10.1177/0300060513507388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
33 Jiang X, Sung YK, Tian W, Qian J, Semenza GL, Nicolls MR. Graft microvascular disease in solid organ transplantation. J Mol Med (Berl) 2014;92:797-810. [PMID: 24880953 DOI: 10.1007/s00109-014-1173-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
34 Yu J, Zanotti S, Walia B, Jellison E, Sanjay A, Canalis E. The Hajdu Cheney Mutation Is a Determinant of B-Cell Allocation of the Splenic Marginal Zone. Am J Pathol 2018;188:149-59. [PMID: 29037852 DOI: 10.1016/j.ajpath.2017.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
35 Koch U, Radtke F. Notch in T-ALL: new players in a complex disease. Trends in Immunology 2011;32:434-42. [DOI: 10.1016/j.it.2011.06.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
36 Huang QB, Ma X, Li HZ, Ai Q, Liu SW, Zhang Y, Gao Y, Fan Y, Ni D, Wang BJ, Zhang X. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis. Oncotarget 2014;5:3066-75. [PMID: 24931473 DOI: 10.18632/oncotarget.1827] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
37 Kubota Y, Takubo K, Shimizu T, Ohno H, Kishi K, Shibuya M, Saya H, Suda T. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med 2009;206:1089-102. [PMID: 19398755 DOI: 10.1084/jem.20081605] [Cited by in Crossref: 249] [Cited by in F6Publishing: 231] [Article Influence: 19.2] [Reference Citation Analysis]
38 Kalkunte S, Huang Z, Lippe E, Kumar S, Robertson LW, Sharma S. Polychlorinated biphenyls target Notch/Dll and VEGF R2 in the mouse placenta and human trophoblast cell lines for their anti-angiogenic effects. Sci Rep 2017;7:39885. [PMID: 28071720 DOI: 10.1038/srep39885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
39 Liu Z, Fan F, Wang A, Zheng S, Lu Y. Dll4-Notch signaling in regulation of tumor angiogenesis. J Cancer Res Clin Oncol 2014;140:525-36. [DOI: 10.1007/s00432-013-1534-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
40 Lv W, Chen L, Sun SZ. Detection of Delta-like 4 expression in gastric cancer and its clinical significance by tissue microarray. Shijie Huaren Xiaohua Zazhi 2008; 16(9): 956-961 [DOI: 10.11569/wcjd.v16.i9.956] [Reference Citation Analysis]
41 Folkman J. Tumor Angiogenesis: from Bench to Bedside. In: Marmé D, Fusenig N, editors. Tumor Angiogenesis. Berlin: Springer Berlin Heidelberg; 2008. pp. 3-28. [DOI: 10.1007/978-3-540-33177-3_1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
42 Roodink I, Leenders WP. Targeted therapies of cancer: Angiogenesis inhibition seems not enough. Cancer Letters 2010;299:1-10. [DOI: 10.1016/j.canlet.2010.09.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 87] [Article Influence: 3.4] [Reference Citation Analysis]
43 Han J, Zúñiga-Pflücker JC. High-Oxygen Submersion Fetal Thymus Organ Cultures Enable FOXN1-Dependent and -Independent Support of T Lymphopoiesis. Front Immunol 2021;12:652665. [PMID: 33859647 DOI: 10.3389/fimmu.2021.652665] [Reference Citation Analysis]
44 Hijaz M, Das S, Mert I, Gupta A, Al-Wahab Z, Tebbe C, Dar S, Chhina J, Giri S, Munkarah A, Seal S, Rattan R. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer. BMC Cancer 2016;16:220. [PMID: 26979107 DOI: 10.1186/s12885-016-2206-4] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 12.3] [Reference Citation Analysis]
45 Rota R, Ciarapica R, Miele L, Locatelli F. Notch signaling in pediatric soft tissue sarcomas. BMC Med 2012;10:141. [PMID: 23158439 DOI: 10.1186/1741-7015-10-141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
46 Ren B, Rose JB, Liu Y, Jaskular-Sztul R, Contreras C, Beck A, Chen H. Heterogeneity of Vascular Endothelial Cells, De Novo Arteriogenesis and Therapeutic Implications in Pancreatic Neuroendocrine Tumors. J Clin Med 2019;8:E1980. [PMID: 31739580 DOI: 10.3390/jcm8111980] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Vinson KE, George DC, Fender AW, Bertrand FE, Sigounas G. The Notch pathway in colorectal cancer. Int J Cancer. 2016;138:1835-1842. [PMID: 26264352 DOI: 10.1002/ijc.29800] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 9.4] [Reference Citation Analysis]
48 Lee SH, Lee S, Yang H, Song S, Kim K, Saunders TL, Yoon JK, Koh GY, Kim I. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis. Circ Res. 2014;115:215-226. [PMID: 24755984 DOI: 10.1161/circresaha.115.303142] [Cited by in Crossref: 53] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
49 Kim YH, Hu H, Guevara-Gallardo S, Lam MT, Fong SY, Wang RA. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. Development 2008;135:3755-64. [PMID: 18952909 DOI: 10.1242/dev.022475] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 7.3] [Reference Citation Analysis]
50 Moustakas A, Kreisl TN. New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab. Onco Targets Ther 2010;3:27-38. [PMID: 20616955 DOI: 10.2147/ott.s5307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
51 Kim IK, Kim K, Lee E, Oh DS, Park CS, Park S, Yang JM, Kim JH, Kim HS, Shima DT, Kim JH, Hong SH, Cho YH, Kim YH, Park JB, Koh GY, Ju YS, Lee HK, Lee S, Kim I. Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality. J Exp Med 2018;215:963-83. [PMID: 29444818 DOI: 10.1084/jem.20170123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
52 Song K, Wu H, Rahman HN, Dong Y, Wen A, Brophy ML, Wong S, Kwak S, Bielenberg DR, Chen H. Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis. Cell Mol Life Sci 2017;74:393-8. [PMID: 27572288 DOI: 10.1007/s00018-016-2347-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
53 Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 2012;320:130-7. [PMID: 22425960 DOI: 10.1016/j.canlet.2012.03.008] [Cited by in Crossref: 225] [Cited by in F6Publishing: 221] [Article Influence: 22.5] [Reference Citation Analysis]
54 Diaz-Padilla I, Wilson MK, Clarke BA, Hirte HW, Welch SA, Mackay HJ, Biagi JJ, Reedijk M, Weberpals JI, Fleming GF, Wang L, Liu G, Zhou C, Blattler C, Ivy SP, Oza AM. A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia. Gynecol Oncol. 2015;137:216-222. [PMID: 25769658 DOI: 10.1016/j.ygyno.2015.03.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
55 Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Current Opinion in Cell Biology 2009;21:154-65. [DOI: 10.1016/j.ceb.2008.12.012] [Cited by in Crossref: 474] [Cited by in F6Publishing: 449] [Article Influence: 36.5] [Reference Citation Analysis]
56 Baharlou R, Tajik N, Habibi-anbouhi M, Shokrgozar MA, Zarnani A, Shahhosseini F, Behdani M. Generation and characterization of an anti-delta like ligand-4 Nanobody to induce non-productive angiogenesis. Analytical Biochemistry 2018;544:34-41. [DOI: 10.1016/j.ab.2017.12.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
57 Kerr BA, West XZ, Kim YW, Zhao Y, Tischenko M, Cull RM, Phares TW, Peng XD, Bernier-Latmani J, Petrova TV, Adams RH, Hay N, Naga Prasad SV, Byzova TV. Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium. Nat Commun 2016;7:10960. [PMID: 26971877 DOI: 10.1038/ncomms10960] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
58 Yang N, Jiang Y, Zhang H, Sun B, Hou C, Zheng J, Liu Y, Zuo P. Active targeting docetaxel-PLA nanoparticles eradicate circulating lung cancer stem-like cells and inhibit liver metastasis. Mol Pharm 2015;12:232-9. [PMID: 25418453 DOI: 10.1021/mp500568z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
59 Rojas JD, Papadopoulou V, Czernuszewicz TJ, Rajamahendiran RM, Chytil A, Chiang YC, Chong DC, Bautch VL, Rathmell WK, Aylward S, Gessner RC, Dayton PA. Ultrasound Measurement of Vascular Density to Evaluate Response to Anti-Angiogenic Therapy in Renal Cell Carcinoma. IEEE Trans Biomed Eng 2019;66:873-80. [PMID: 30059292 DOI: 10.1109/TBME.2018.2860932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
60 Lee SU, Maeda M, Ishikawa Y, Li SM, Wilson A, Jubb AM, Sakurai N, Weng L, Fiorini E, Radtke F, Yan M, Macdonald HR, Chen CC, Maeda T. LRF-mediated Dll4 repression in erythroblasts is necessary for hematopoietic stem cell maintenance. Blood 2013;121:918-29. [PMID: 23134786 DOI: 10.1182/blood-2012-03-418103] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
61 Ntziachristos P, Lim JS, Sage J, Aifantis I. From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell. 2014;25:318-334. [PMID: 24651013 DOI: 10.1016/j.ccr.2014.02.018] [Cited by in Crossref: 224] [Cited by in F6Publishing: 198] [Article Influence: 28.0] [Reference Citation Analysis]
62 Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358:2039-2049. [PMID: 18463380 DOI: 10.1056/nejmra0706596] [Cited by in Crossref: 1525] [Cited by in F6Publishing: 799] [Article Influence: 108.9] [Reference Citation Analysis]
63 Marcelo KL, Goldie LC, Hirschi KK. Regulation of endothelial cell differentiation and specification. Circ Res. 2013;112:1272-1287. [PMID: 23620236 DOI: 10.1161/circresaha.113.300506] [Cited by in Crossref: 178] [Cited by in F6Publishing: 98] [Article Influence: 19.8] [Reference Citation Analysis]
64 Payton M, Jun T, Wayne W, Yu D, Manoukian R, Chung G, Zhang N, Sun JR, Kaplan-Lefko P, Scully S, Van G, Radinsky R, Kendall R, Oliner J, Coxon A. Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method. Lab Invest 2014;94:1296-308. [PMID: 25243900 DOI: 10.1038/labinvest.2014.116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Li ZQ, Gong LL, Wen ZH, Wang J, Xu CS, Huang XD. Delta-like ligand 4 correlates with endothelial proliferation and vessel maturation in human malignant glioma. Onkologie 2012;35:763-8. [PMID: 23207622 DOI: 10.1159/000345116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
66 Yin Q, Wang W, Cui G, Nan H, Yan L, Zhang W, Zhang S, Wei J. The expression levels of Notch-related signaling molecules in pulmonary microvascular endothelial cells in bleomycin-induced rat pulmonary fibrosis. Physiol Res 2017;66:305-15. [PMID: 27982686 DOI: 10.33549/physiolres.933356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
67 Caporarello N, Lupo G, Olivieri M, Cristaldi M, Cambria MT, Salmeri M, Anfuso CD. Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions (Review). Mol Med Rep 2017;16:4393-402. [PMID: 28791360 DOI: 10.3892/mmr.2017.7179] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
68 Zhang JP, Qin HY, Wang L, Liang L, Zhao XC, Cai WX, Wei YN, Wang CM, Han H. Overexpression of Notch ligand Dll1 in B16 melanoma cells leads to reduced tumor growth due to attenuated vascularization. Cancer Lett 2011;309:220-7. [PMID: 21752535 DOI: 10.1016/j.canlet.2011.06.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
69 Hendriks M, Ramasamy SK. Blood Vessels and Vascular Niches in Bone Development and Physiological Remodeling. Front Cell Dev Biol 2020;8:602278. [PMID: 33330496 DOI: 10.3389/fcell.2020.602278] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
70 Zhang J, Fukuhara S, Sako K, Takenouchi T, Kitani H, Kume T, Koh GY, Mochizuki N. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. J Biol Chem 2011;286:8055-66. [PMID: 21212269 DOI: 10.1074/jbc.M110.192641] [Cited by in Crossref: 76] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
71 Wu JK, Adepoju O, De Silva D, Baribault K, Boscolo E, Bischoff J, Kitajewski J. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis 2010;13:15-23. [PMID: 20069356 DOI: 10.1007/s10456-009-9161-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
72 Oklu R, Walker TG, Wicky S, Hesketh R. Angiogenesis and current antiangiogenic strategies for the treatment of cancer. J Vasc Interv Radiol 2010;21:1791-805; quiz 1806. [PMID: 20980167 DOI: 10.1016/j.jvir.2010.08.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
73 Park SE, Lee J, Lee T, Bae SB, Kang B, Huh YM, Lee SW, Haam S. Comparative hyperthermia effects of silica-gold nanoshells with different surface coverage of gold clusters on epithelial tumor cells. Int J Nanomedicine 2015;10:261-71. [PMID: 26425093 DOI: 10.2147/IJN.S88309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
74 Pindiprolu SKSS, Krishnamurthy PT, Chintamaneni PK. Pharmacological targets of breast cancer stem cells: a review. Naunyn Schmiedebergs Arch Pharmacol. 2018;391:463-479. [PMID: 29476201 DOI: 10.1007/s00210-018-1479-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
75 Hu YY, Zheng MH, Zhang R, Liang YM, Han H. Notch signaling pathway and cancer metastasis. Adv Exp Med Biol. 2012;727:186-198. [PMID: 22399348 DOI: 10.1007/978-1-4614-0899-4_14] [Cited by in Crossref: 85] [Cited by in F6Publishing: 76] [Article Influence: 8.5] [Reference Citation Analysis]
76 Aggarwal V, Tuli HS, Varol M, Tuorkey M, Sak K, Parashar NC, Barwal TS, Sharma U, Iqubal A, Parashar G, Jain A. NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target. Crit Rev Oncol Hematol 2021;164:103403. [PMID: 34214610 DOI: 10.1016/j.critrevonc.2021.103403] [Reference Citation Analysis]
77 You C, Sandalcioglu IE, Dammann P, Felbor U, Sure U, Zhu Y. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. J Cell Mol Med 2013;17:407-18. [PMID: 23388056 DOI: 10.1111/jcmm.12022] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 6.2] [Reference Citation Analysis]
78 Park JS, Kim SH, Kim K, Jin CH, Choi KY, Jang J, Choi Y, Gwon AR, Baik SH, Yun UJ, Chae SY, Lee S, Kang YM, Lee KC, Arumugam TV, Mattson MP, Park JH, Jo DG. Inhibition of notch signalling ameliorates experimental inflammatory arthritis. Ann Rheum Dis 2015;74:267-74. [PMID: 24255545 DOI: 10.1136/annrheumdis-2013-203467] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
79 Falcon BL, O'Clair B, McClure D, Evans GF, Stewart J, Swearingen ML, Chen Y, Allard K, Lee LN, Neote K, McEwen DP, Uhlik MT, Chintharlapalli S. Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition. J Hematol Oncol 2013;6:31. [PMID: 23622716 DOI: 10.1186/1756-8722-6-31] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
80 Sawaguchi S, Varshney S, Ogawa M, Sakaidani Y, Yagi H, Takeshita K, Murohara T, Kato K, Sundaram S, Stanley P, Okajima T. O-GlcNAc on NOTCH1 EGF repeats regulates ligand-induced Notch signaling and vascular development in mammals. Elife 2017;6:e24419. [PMID: 28395734 DOI: 10.7554/eLife.24419] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 10.2] [Reference Citation Analysis]
81 Kałafut J, Czerwonka A, Anameriç A, Przybyszewska-Podstawka A, Misiorek JO, Rivero-Müller A, Nees M. Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas. Cancers (Basel) 2021;13:6219. [PMID: 34944837 DOI: 10.3390/cancers13246219] [Reference Citation Analysis]
82 Niu G, Chen X. Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets. 2010;11:1000-1017. [PMID: 20426765 DOI: 10.2174/138945010791591395] [Cited by in Crossref: 188] [Cited by in F6Publishing: 164] [Article Influence: 15.7] [Reference Citation Analysis]
83 Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB, Niessen K, Plowman GD. Chronic DLL4 blockade induces vascular neoplasms. Nature 2010;463:E6-7. [DOI: 10.1038/nature08751] [Cited by in Crossref: 213] [Cited by in F6Publishing: 194] [Article Influence: 17.8] [Reference Citation Analysis]
84 Hernandez SL, Banerjee D, Garcia A, Kangsamaksin T, Cheng WY, Anastassiou D, Funahashi Y, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ. Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis. Vasc Cell 2013;5:17. [PMID: 24066611 DOI: 10.1186/2045-824X-5-17] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
85 Joosten SC, Hamming L, Soetekouw PM, Aarts MJ, Veeck J, van Engeland M, Tjan-Heijnen VC. Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives. Biochim Biophys Acta 2015;1855:1-16. [PMID: 25446042 DOI: 10.1016/j.bbcan.2014.11.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
86 Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 2010;10:505-14. [PMID: 20574450 DOI: 10.1038/nrc2868] [Cited by in Crossref: 465] [Cited by in F6Publishing: 444] [Article Influence: 38.8] [Reference Citation Analysis]
87 Hagenbeek TJ, Wu X, Choy L, Sanchez-irizarry C, Seshagiri S, Stinson J, Siebel CW, Spits H. Murine Pten−/− T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit. Cancer Letters 2014;346:237-48. [DOI: 10.1016/j.canlet.2013.12.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
88 Kume T. Ligand-dependent Notch signaling in vascular formation. Adv Exp Med Biol 2012;727:210-22. [PMID: 22399350 DOI: 10.1007/978-1-4614-0899-4_16] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
89 Colombo M, Mirandola L, Platonova N, Apicella L, Basile A, Figueroa AJ, Cobos E, Chiriva-Internati M, Chiaramonte R. Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes. Leukemia. 2013;27:1009-1018. [PMID: 23307030 DOI: 10.1038/leu.2013.6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 6.2] [Reference Citation Analysis]
90 Phng L, Gerhardt H. Angiogenesis: A Team Effort Coordinated by Notch. Developmental Cell 2009;16:196-208. [DOI: 10.1016/j.devcel.2009.01.015] [Cited by in Crossref: 557] [Cited by in F6Publishing: 515] [Article Influence: 42.8] [Reference Citation Analysis]
91 Funahashi Y, Shawber CJ, Vorontchikhina M, Sharma A, Outtz HH, Kitajewski J. Notch regulates the angiogenic response via induction of VEGFR-1. J Angiogenes Res 2010;2:3. [PMID: 20298529 DOI: 10.1186/2040-2384-2-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
92 Purow B. Notch inhibitors as a new tool in the war on cancer: a pathway to watch. Curr Pharm Biotechnol. 2009;10:154-160. [PMID: 19199947 DOI: 10.2174/138920109787315060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
93 Krishna BM, Jana S, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS. Notch signaling in breast cancer: From pathway analysis to therapy. Cancer Lett 2019;461:123-31. [PMID: 31326555 DOI: 10.1016/j.canlet.2019.07.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
94 Bargehr J, Low L, Cheung C, Bernard WG, Iyer D, Bennett MR, Gambardella L, Sinha S. Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network Formation. Stem Cells Transl Med 2016;5:946-59. [PMID: 27194743 DOI: 10.5966/sctm.2015-0282] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
95 Harris PJ, Speranza G, Dansky Ullmann C. Targeting embryonic signaling pathways in cancer therapy. Expert Opinion on Therapeutic Targets 2012;16:131-45. [DOI: 10.1517/14728222.2011.645808] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
96 Boo Y, Fisher JC, Haley MJ, Cowles RA, Kandel JJ, Yamashiro DJ. Vascular characterization of clear cell sarcoma of the kidney in a child: a case report and review. Journal of Pediatric Surgery 2009;44:2031-6. [DOI: 10.1016/j.jpedsurg.2009.06.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
97 Zhang CC, Yan Z, Giddabasappa A, Lappin PB, Painter CL, Zhang Q, Li G, Goodman J, Simmons B, Pascual B. Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib. Cancer Med. 2014;3:462-471. [PMID: 24573979 DOI: 10.1002/cam4.215] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
98 Sorrentino C, Cuneo A, Roti G. Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies. Mediterr J Hematol Infect Dis 2019;11:e2019037. [PMID: 31308913 DOI: 10.4084/MJHID.2019.037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
99 Bentley K, Gerhardt H, Bates PA. Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation. Journal of Theoretical Biology 2008;250:25-36. [DOI: 10.1016/j.jtbi.2007.09.015] [Cited by in Crossref: 165] [Cited by in F6Publishing: 148] [Article Influence: 11.8] [Reference Citation Analysis]
100 Moya IM, Umans L, Maas E, Pereira PN, Beets K, Francis A, Sents W, Robertson EJ, Mummery CL, Huylebroeck D. Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. Dev Cell. 2012;22:501-514. [PMID: 22364862 DOI: 10.1016/j.devcel.2012.01.007] [Cited by in Crossref: 158] [Cited by in F6Publishing: 149] [Article Influence: 15.8] [Reference Citation Analysis]
101 Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141:140-149. [PMID: 24076266 DOI: 10.1016/j.pharmthera.2013.09.005] [Cited by in Crossref: 240] [Cited by in F6Publishing: 229] [Article Influence: 26.7] [Reference Citation Analysis]
102 Espinoza I, Pochampally R, Xing F, Watabe K, Miele L. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther 2013;6:1249-59. [PMID: 24043949 DOI: 10.2147/OTT.S36162] [Cited by in Crossref: 31] [Cited by in F6Publishing: 83] [Article Influence: 3.4] [Reference Citation Analysis]
103 Billiard F, Kirshner JR, Tait M, Danave A, Taheri S, Zhang W, Waite JC, Olson K, Chen G, Coetzee S, Hylton D, Murphy AJ, Yancopoulos GD, Thurston G, Skokos D. Ongoing Dll4-Notch signaling is required for T-cell homeostasis in the adult thymus. Eur J Immunol 2011;41:2207-16. [PMID: 21598246 DOI: 10.1002/eji.201041343] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
104 Pontes-Quero S, Fernández-Chacón M, Luo W, Lunella FF, Casquero-Garcia V, Garcia-Gonzalez I, Hermoso A, Rocha SF, Bansal M, Benedito R. High mitogenic stimulation arrests angiogenesis. Nat Commun 2019;10:2016. [PMID: 31043605 DOI: 10.1038/s41467-019-09875-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
105 Garvalov BK, Acker T. Cancer stem cells: a new framework for the design of tumor therapies. J Mol Med 2011;89:95-107. [DOI: 10.1007/s00109-010-0685-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
106 Rabascio C, Bertolini F. Blood-based biomarkers for the optimization of anti-angiogenic therapies. Cancers (Basel) 2010;2:1027-39. [PMID: 24281105 DOI: 10.3390/cancers2021027] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Drouillard A, Puleo F, Bachet JB, Ouazzani S, Calomme A, Demetter P, Verset G, Van Laethem JL, Maréchal R. DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. Br J Cancer 2016;115:1245-52. [PMID: 27755532 DOI: 10.1038/bjc.2016.319] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
108 Nimmagadda S, Geetha-Loganathan P, Pröls F, Scaal M, Christ B, Huang R. Expression pattern of Dll4 during chick embryogenesis. Histochem Cell Biol 2007;128:147-52. [PMID: 17605027 DOI: 10.1007/s00418-007-0306-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
109 Talchai C, Xuan S, Kitamura T, DePinho RA, Accili D. Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet 2012;44:406-12, S1. [PMID: 22406641 DOI: 10.1038/ng.2215] [Cited by in Crossref: 105] [Cited by in F6Publishing: 97] [Article Influence: 10.5] [Reference Citation Analysis]
110 Strilić B, Eglinger J, Krieg M, Zeeb M, Axnick J, Babál P, Müller DJ, Lammert E. Electrostatic cell-surface repulsion initiates lumen formation in developing blood vessels. Curr Biol 2010;20:2003-9. [PMID: 20970336 DOI: 10.1016/j.cub.2010.09.061] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 8.3] [Reference Citation Analysis]
111 Brennan FR, Cavagnaro J, McKeever K, Ryan PC, Schutten MM, Vahle J, Weinbauer GF, Marrer-Berger E, Black LE. Safety testing of monoclonal antibodies in non-human primates: Case studies highlighting their impact on human risk assessment. MAbs 2018;10:1-17. [PMID: 28991509 DOI: 10.1080/19420862.2017.1389364] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
112 Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT. Angiogenesis in brain tumours. Nat Rev Neurosci 2007;8:610-22. [DOI: 10.1038/nrn2175] [Cited by in Crossref: 898] [Cited by in F6Publishing: 834] [Article Influence: 59.9] [Reference Citation Analysis]
113 Sakakibara S, Tosato G. Regulation of angiogenesis in malignancies associated with Epstein–Barr virus and Kaposi’s sarcoma-associated herpes virus. Future Microbiology 2009;4:903-17. [DOI: 10.2217/fmb.09.49] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
114 Medinger M, Mross K. Clinical trials with anti-angiogenic agents in hematological malignancies. J Angiogenes Res 2010;2:10. [PMID: 20569499 DOI: 10.1186/2040-2384-2-10] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
115 Huang J, Hu W, Hu L, Previs RA, Dalton HJ, Yang XY, Sun Y, McGuire M, Rupaimoole R, Nagaraja AS, Kang Y, Liu T, Nick AM, Jennings NB, Coleman RL, Jaffe RB, Sood AK. Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth. Mol Cancer Ther. 2016;15:1344-1352. [PMID: 27009216 DOI: 10.1158/1535-7163.mct-15-0144] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
116 Cucu I, Nicolescu MI. A Synopsis of Signaling Crosstalk of Pericytes and Endothelial Cells in Salivary Gland. Dentistry Journal 2021;9:144. [DOI: 10.3390/dj9120144] [Reference Citation Analysis]
117 Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene. 2008;27:5132-5137. [PMID: 18758482 DOI: 10.1038/onc.2008.227] [Cited by in Crossref: 180] [Cited by in F6Publishing: 174] [Article Influence: 12.9] [Reference Citation Analysis]
118 Tarasova A, Haylock D, Winkler D. Principal signalling complexes in haematopoiesis: Structural aspects and mimetic discovery. Cytokine & Growth Factor Reviews 2011;22:231-53. [DOI: 10.1016/j.cytogfr.2011.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
119 Boles KS, Schmieder AH, Koch AW, Carano RA, Wu Y, Caruthers SD, Tong RK, Stawicki S, Hu G, Scott MJ, Zhang H, Reynolds BA, Wickline SA, Lanza GM. MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model. FASEB J 2010;24:4262-70. [PMID: 20585027 DOI: 10.1096/fj.10-157933] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
120 Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer. 2010;116:5676-5685. [PMID: 20737536 DOI: 10.1002/cncr.25551] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 7.4] [Reference Citation Analysis]
121 Kimura H, Miyashita H, Suzuki Y, Kobayashi M, Watanabe K, Sonoda H, Ohta H, Fujiwara T, Shimosegawa T, Sato Y. Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood 2009;113:4810-8. [DOI: 10.1182/blood-2008-07-170316] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 7.6] [Reference Citation Analysis]
122 Zhou W, Wang G, Guo S. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2013;1836:304-320. [PMID: 24183943 DOI: 10.1016/j.bbcan.2013.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
123 Lakatos G, Tulassay Z. [Antiangiogenic therapy for gastrointestinal tumors]. Orv Hetil 2008;149:2317-24. [PMID: 19042183 DOI: 10.1556/OH.2008.28496] [Reference Citation Analysis]
124 Kang M, Jiang B, Xu B, Lu W, Guo Q, Xie Q, Zhang B, Dong X, Chen D, Wu Y. Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer. Cancer Lett 2013;330:11-21. [PMID: 23200678 DOI: 10.1016/j.canlet.2012.11.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
125 Espinosa-Sánchez A, Suárez-Martínez E, Sánchez-Díaz L, Carnero A. Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness. Front Oncol 2020;10:1533. [PMID: 32984007 DOI: 10.3389/fonc.2020.01533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Bentley K, Mariggi G, Gerhardt H, Bates PA. Tipping the balance: robustness of tip cell selection, migration and fusion in angiogenesis. PLoS Comput Biol 2009;5:e1000549. [PMID: 19876379 DOI: 10.1371/journal.pcbi.1000549] [Cited by in Crossref: 147] [Cited by in F6Publishing: 131] [Article Influence: 11.3] [Reference Citation Analysis]
127 Shojaei F, Ferrara N. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. Drug Resist Updat 2008;11:219-30. [PMID: 18948057 DOI: 10.1016/j.drup.2008.09.001] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
128 Trindade A, Djokovic D, Gigante J, Badenes M, Pedrosa AR, Fernandes AC, Lopes-da-Costa L, Krasnoperov V, Liu R, Gill PS, Duarte A. Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis. PLoS One 2012;7:e29863. [PMID: 22279550 DOI: 10.1371/journal.pone.0029863] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
129 Rizzo P, Osipo C, Pannuti A, Golde T, Osborne B, Miele L. Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer. Adv Enzyme Regul 2009;49:134-41. [PMID: 19344631 DOI: 10.1016/j.advenzreg.2009.01.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
130 Kumar R, Juillerat-jeanneret L, Golshayan D. Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases. J Med Chem 2016;59:7719-37. [DOI: 10.1021/acs.jmedchem.5b01516] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
131 Suchting S, Freitas C, Eichmann A. L’angiogenèse passe sous contrôle du couple Delta-Notch. Med Sci (Paris) 2007;23:347-8. [DOI: 10.1051/medsci/2007234347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
132 Wallgard E, Larsson E, He L, Hellström M, Armulik A, Nisancioglu MH, Genove G, Lindahl P, Betsholtz C. Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. Arterioscler Thromb Vasc Biol 2008;28:1469-76. [PMID: 18483404 DOI: 10.1161/ATVBAHA.108.165738] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
133 Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 2010;60:222-243. [PMID: 20554717 DOI: 10.3322/caac.20075] [Cited by in Crossref: 311] [Cited by in F6Publishing: 273] [Article Influence: 25.9] [Reference Citation Analysis]
134 Yang B, Huang CZ, Yu T, Zhou SN, Liu Q, Liu GJ, Chen S, Han FH. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus. Anticancer Drugs 2017;28:531-9. [PMID: 28177944 DOI: 10.1097/CAD.0000000000000483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
135 Huang MT, Dai YS, Chou YB, Juan YH, Wang CC, Chiang BL. Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. J Immunol 2009;183:4745-54. [PMID: 19752226 DOI: 10.4049/jimmunol.0804371] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
136 Jubb AM, Miller KD, Rugo HS, Harris AL, Chen D, Reimann JD, Cobleigh MA, Schmidt M, Langmuir VK, Hillan KJ, Chen DS, Koeppen H. Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. Clin Cancer Res 2011;17:372-81. [PMID: 21224365 DOI: 10.1158/1078-0432.CCR-10-1791] [Cited by in Crossref: 77] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
137 Larrivée B, Freitas C, Suchting S, Brunet I, Eichmann A. Guidance of vascular development: lessons from the nervous system. Circ Res. 2009;104:428-441. [PMID: 19246687 DOI: 10.1161/circresaha.108.188144] [Cited by in Crossref: 179] [Cited by in F6Publishing: 104] [Article Influence: 13.8] [Reference Citation Analysis]
138 Tran IT, Sandy AR, Carulli AJ, Ebens C, Chung J, Shan GT, Radojcic V, Friedman A, Gridley T, Shelton A, Reddy P, Samuelson LC, Yan M, Siebel CW, Maillard I. Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J Clin Invest 2013;123:1590-604. [PMID: 23454750 DOI: 10.1172/JCI65477] [Cited by in Crossref: 107] [Cited by in F6Publishing: 71] [Article Influence: 11.9] [Reference Citation Analysis]
139 Ran Y, Hossain F, Pannuti A, Lessard CB, Ladd GZ, Jung JI, Minter LM, Osborne BA, Miele L, Golde TE. γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct. EMBO Mol Med 2017;9:950-66. [PMID: 28539479 DOI: 10.15252/emmm.201607265] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 16.3] [Reference Citation Analysis]
140 Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, Fitch-Bruhns M, Lazetic S, Park IK, Sato A, Satyal S, Wang X, Clarke MF, Lewicki J, Gurney A. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell. 2009;5:168-177. [PMID: 19664991 DOI: 10.1016/j.stem.2009.05.019] [Cited by in Crossref: 285] [Cited by in F6Publishing: 252] [Article Influence: 21.9] [Reference Citation Analysis]
141 Yan X, Yang Z, Chen Y, Li N, Wang L, Dou G, Liu Y, Duan J, Feng L, Deng S, Han H, Zhang P. Endothelial cells-targeted soluble human Delta-like 4 suppresses both physiological and pathological ocular angiogenesis. Sci China Life Sci 2015;58:425-31. [DOI: 10.1007/s11427-015-4834-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
142 Roncal C, Buysschaert I, Chorianopoulos E, Georgiadou M, Meilhac O, Demol M, Michel J, Vinckier S, Moons L, Carmeliet P. Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance. J Pathol 2008;216:236-44. [DOI: 10.1002/path.2408] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
143 Afzal A, Shaw LC, Ljubimov AV, Boulton ME, Segal MS, Grant MB. Retinal and choroidal microangiopathies: therapeutic opportunities. Microvasc Res 2007;74:131-44. [PMID: 17585951 DOI: 10.1016/j.mvr.2007.04.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
144 Cao L, Arany PR, Kim J, Rivera-Feliciano J, Wang YS, He Z, Rask-Madsen C, King GL, Mooney DJ. Modulating Notch signaling to enhance neovascularization and reperfusion in diabetic mice. Biomaterials 2010;31:9048-56. [PMID: 20800279 DOI: 10.1016/j.biomaterials.2010.08.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
145 Masuda S, Izpisua Belmonte JC. A recipe for targeted therapy in prostate cancer. Nat Rev Urol 2014;11:419. [PMID: 24980194 DOI: 10.1038/nrurol.2013.110-c1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
146 Zhang P, Yan X, Chen Y, Yang Z, Han H. Notch signaling in blood vessels: from morphogenesis to homeostasis. Sci China Life Sci 2014;57:774-80. [PMID: 25104449 DOI: 10.1007/s11427-014-4716-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
147 Christopoulos PF, Gjølberg TT, Krüger S, Haraldsen G, Andersen JT, Sundlisæter E. Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases. Front Immunol 2021;12:668207. [PMID: 33912195 DOI: 10.3389/fimmu.2021.668207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Khan KA, Bicknell R. Anti-angiogenic alternatives to VEGF blockade. Clin Exp Metastasis 2016;33:197-210. [PMID: 26620208 DOI: 10.1007/s10585-015-9769-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
149 Chung J, Radojcic V, Perkey E, Parnell TJ, Niknafs Y, Jin X, Friedman A, Labrecque N, Blazar BR, Brennan TV, Siebel CW, Maillard I. Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4+ T Cells in Graft-versus-Host Disease. J Immunol 2019;203:557-68. [PMID: 31182480 DOI: 10.4049/jimmunol.1900192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
150 Mayo V, Bowles AC, Wubker LE, Ortiz I, Cordoves AM, Cote RJ, Correa D, Agarwal A. Human-derived osteoblast-like cells and pericyte-like cells induce distinct metastatic phenotypes in primary breast cancer cells. Exp Biol Med (Maywood) 2021;246:971-85. [PMID: 33210551 DOI: 10.1177/1535370220971599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Nissen LJ, Cao R, Hedlund EM, Wang Z, Zhao X, Wetterskog D, Funa K, Bråkenhielm E, Cao Y. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest 2007;117:2766-77. [PMID: 17909625 DOI: 10.1172/JCI32479] [Cited by in Crossref: 199] [Cited by in F6Publishing: 103] [Article Influence: 13.3] [Reference Citation Analysis]
152 Chen M, Li Y, Huang X, Gu Y, Li S, Yin P, Zhang L, Tang P. Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis. Bone Res 2021;9:21. [PMID: 33753717 DOI: 10.1038/s41413-021-00138-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Gridley T. Notch signaling in the vasculature. Curr Top Dev Biol 2010;92:277-309. [PMID: 20816399 DOI: 10.1016/S0070-2153(10)92009-7] [Cited by in Crossref: 178] [Cited by in F6Publishing: 115] [Article Influence: 14.8] [Reference Citation Analysis]
154 Wu K, Xu L, Zhang L, Lin Z, Hou J. High Jagged1 Expression Predicts Poor Outcome in Clear Cell Renal Cell Carcinoma. Japanese Journal of Clinical Oncology 2011;41:411-6. [DOI: 10.1093/jjco/hyq205] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
155 Kubota Y, Takubo K, Hirashima M, Nagoshi N, Kishi K, Okuno Y, Nakamura-Ishizu A, Sano K, Murakami M, Ema M, Omatsu Y, Takahashi S, Nagasawa T, Shibuya M, Okano H, Suda T. Isolation and function of mouse tissue resident vascular precursors marked by myelin protein zero. J Exp Med. 2011;208:949-960. [PMID: 21536740 DOI: 10.1084/jem.20102187] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
156 Scianna M, Bassino E, Munaron L. A cellular Potts model analyzing differentiated cell behavior during in vivo vascularization of a hypoxic tissue. Computers in Biology and Medicine 2015;63:143-56. [DOI: 10.1016/j.compbiomed.2015.05.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
157 Kunanopparat A, Issara-Amphorn J, Leelahavanichkul A, Sanpavat A, Patumraj S, Tangkijvanich P, Palaga T, Hirankarn N. Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication. World J Gastroenterol 2018; 24(34): 3861-3870 [PMID: 30228780 DOI: 10.3748/wjg.v24.i34.3861] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
158 Aster JC, Blacklow SC. Targeting the Notch pathway: twists and turns on the road to rational therapeutics. J Clin Oncol 2012;30:2418-20. [PMID: 22585704 DOI: 10.1200/JCO.2012.42.0992] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
159 Seufferlein T, Ahn J, Krndija D, Lother U, Adler G, von Wichert G. Tumor biology and cancer therapy - an evolving relationship. Cell Commun Signal 2009;7:19. [PMID: 19678929 DOI: 10.1186/1478-811X-7-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
160 Kalén M, Heikura T, Karvinen H, Nitzsche A, Weber H, Esser N, Ylä-Herttuala S, Hellström M. Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion. PLoS One 2011;6:e18709. [PMID: 21533193 DOI: 10.1371/journal.pone.0018709] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
161 Müller-Brüsselbach S, Kömhoff M, Rieck M, Meissner W, Kaddatz K, Adamkiewicz J, Keil B, Klose KJ, Moll R, Burdick AD, Peters JM, Müller R. Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice. EMBO J 2007;26:3686-98. [PMID: 17641685 DOI: 10.1038/sj.emboj.7601803] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 4.9] [Reference Citation Analysis]
162 Yahyanejad S, Theys J, Vooijs M. Targeting Notch to overcome radiation resistance. Oncotarget 2016;7:7610-28. [PMID: 26713603 DOI: 10.18632/oncotarget.6714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
163 Morell CM, Strazzabosco M. Notch signaling and new therapeutic options in liver disease. J Hepatol. 2014;60:885-890. [PMID: 24308992 DOI: 10.1016/j.jhep.2013.11.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 7.6] [Reference Citation Analysis]
164 Dou GR, Wang L, Wang YS, Han H. Notch signaling in ocular vasculature development and diseases. Mol Med 2012;18:47-55. [PMID: 21989947 DOI: 10.2119/molmed.2011.00256] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
165 Qin L, Bromberg-White JL, Qian CN. Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed. Adv Cancer Res 2012;113:191-239. [PMID: 22429856 DOI: 10.1016/B978-0-12-394280-7.00006-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
166 Chappell JC, Payne LB, Rathmell WK. Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers. J Clin Invest 2019;129:442-51. [PMID: 30614813 DOI: 10.1172/JCI120855] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
167 Zhao S, Yu W, Ukon N, Tan C, Nishijima KI, Shimizu Y, Higashikawa K, Shiga T, Yamashita H, Tamaki N, Kuge Y. Elimination of tumor hypoxia by eribulin demonstrated by 18F-FMISO hypoxia imaging in human tumor xenograft models. EJNMMI Res 2019;9:51. [PMID: 31161539 DOI: 10.1186/s13550-019-0521-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
168 Ferrara N. Pathways mediating VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev. 2010;21:21-26. [PMID: 20005148 DOI: 10.1016/j.cytogfr.2009.11.003] [Cited by in Crossref: 199] [Cited by in F6Publishing: 178] [Article Influence: 15.3] [Reference Citation Analysis]
169 Teodorczyk M, Schmidt MHH. Notching on Cancer's Door: Notch Signaling in Brain Tumors. Front Oncol 2014;4:341. [PMID: 25601901 DOI: 10.3389/fonc.2014.00341] [Cited by in Crossref: 24] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
170 Flister MJ, Tsaih SW, Stoddard A, Plasterer C, Jagtap J, Parchur AK, Sharma G, Prisco AR, Lemke A, Murphy D, Al-Gizawiy M, Straza M, Ran S, Geurts AM, Dwinell MR, Greene AS, Bergom C, LaViolette PS, Joshi A. Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer. Breast Cancer Res Treat 2017;165:53-64. [PMID: 28567545 DOI: 10.1007/s10549-017-4311-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
171 High FA, Lu MM, Pear WS, Loomes KM, Kaestner KH, Epstein JA. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci U S A 2008;105:1955-9. [PMID: 18245384 DOI: 10.1073/pnas.0709663105] [Cited by in Crossref: 221] [Cited by in F6Publishing: 207] [Article Influence: 15.8] [Reference Citation Analysis]
172 Sosa Iglesias V, Giuranno L, Dubois LJ, Theys J, Vooijs M. Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting? Front Oncol 2018;8:267. [PMID: 30087852 DOI: 10.3389/fonc.2018.00267] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis]
173 Fens MH, Storm G, Schiffelers RM. Tumor vasculature as target for therapeutic intervention. Expert Opinion on Investigational Drugs 2010;19:1321-38. [DOI: 10.1517/13543784.2010.524204] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
174 Huang Q, Li J, Zheng J, Wei A. The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma. J Cancer. 2019;10:1570-1579. [PMID: 31031867 DOI: 10.7150/jca.26847] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
175 Thurston G, Kitajewski J. VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer. 2008;99:1204-1209. [PMID: 18827808 DOI: 10.1038/sj.bjc.6604484] [Cited by in Crossref: 116] [Cited by in F6Publishing: 107] [Article Influence: 8.3] [Reference Citation Analysis]
176 Cao Z, Ding BS, Guo P, Lee SB, Butler JM, Casey SC, Simons M, Tam W, Felsher DW, Shido K, Rafii A, Scandura JM, Rafii S. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell 2014;25:350-65. [PMID: 24651014 DOI: 10.1016/j.ccr.2014.02.005] [Cited by in Crossref: 142] [Cited by in F6Publishing: 130] [Article Influence: 17.8] [Reference Citation Analysis]
177 Benedito R, Trindade A, Hirashima M, Henrique D, da Costa LL, Rossant J, Gill PS, Duarte A. Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli. BMC Dev Biol 2008;8:117. [PMID: 19087347 DOI: 10.1186/1471-213X-8-117] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
178 Kangsamaksin T, Murtomaki A, Kofler NM, Cuervo H, Chaudhri RA, Tattersall IW, Rosenstiel PE, Shawber CJ, Kitajewski J. NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth. Cancer Discov 2015;5:182-97. [PMID: 25387766 DOI: 10.1158/2159-8290.CD-14-0650] [Cited by in Crossref: 87] [Cited by in F6Publishing: 59] [Article Influence: 10.9] [Reference Citation Analysis]
179 Schneider M, Kumar V, Nordstrøm LU, Feng L, Takeuchi H, Hao H, Luca VC, Garcia KC, Stanley P, Wu P, Haltiwanger RS. Inhibition of Delta-induced Notch signaling using fucose analogs. Nat Chem Biol 2018;14:65-71. [PMID: 29176671 DOI: 10.1038/nchembio.2520] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
180 Soda Y, Myskiw C, Rommel A, Verma IM. Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med (Berl) 2013;91:439-48. [PMID: 23512266 DOI: 10.1007/s00109-013-1019-z] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 10.6] [Reference Citation Analysis]
181 Huang Y, Lin L, Shanker A, Malhotra A, Yang L, Dikov MM, Carbone DP. Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth. Cancer Res 2011;71:6122-31. [PMID: 21825014 DOI: 10.1158/0008-5472.CAN-10-4366] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
182 Otsu K, Das S, Houser SD, Quadri SK, Bhattacharya S, Bhattacharya J. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood. 2009;113:4197-4205. [PMID: 19036701 DOI: 10.1182/blood-2008-09-176198] [Cited by in Crossref: 202] [Cited by in F6Publishing: 190] [Article Influence: 14.4] [Reference Citation Analysis]
183 Tian W, Cao C, Shu L, Wu F. Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer. Onco Targets Ther 2020;13:12113-29. [PMID: 33262610 DOI: 10.2147/OTT.S276150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
184 Mettouchi A. The role of extracellular matrix in vascular branching morphogenesis. Cell Adh Migr 2012;6:528-34. [PMID: 23257831 DOI: 10.4161/cam.22862] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
185 Wood S, Feng J, Chung J, Radojcic V, Sandy-Sloat AR, Friedman A, Shelton A, Yan M, Siebel CW, Bishop DK, Maillard I. Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation. J Immunol 2015;194:2899-908. [PMID: 25687759 DOI: 10.4049/jimmunol.1402034] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
186 Zoller F, Markert A, Barthe P, Zhao W, Weichert W, Askoxylakis V, Altmann A, Mier W, Haberkorn U. Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor-Targeting Miniproteins. Angew Chem Int Ed 2012;51:13136-9. [DOI: 10.1002/anie.201203857] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
187 Nichol D, Stuhlmann H. EGFL7: a unique angiogenic signaling factor in vascular development and disease. Blood 2012;119:1345-52. [PMID: 22160377 DOI: 10.1182/blood-2011-10-322446] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 8.2] [Reference Citation Analysis]
188 Funahashi Y, Shawber CJ, Sharma A, Kanamaru E, Choi YK, Kitajewski J. Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Vasc Cell 2011;3:2. [PMID: 21349159 DOI: 10.1186/2045-824X-3-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
189 Liu YR, Guan YY, Luan X, Lu Q, Wang C, Liu HJ, Gao YG, Yang SC, Dong X, Chen HZ, Fang C. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy. Biomaterials 2015;42:161-71. [PMID: 25542804 DOI: 10.1016/j.biomaterials.2014.11.039] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
190 Yu Y, Zhao Y, Zhou G, Wang X. Therapeutic Efficacy of Delta-Like Ligand 4 Gene Vaccine Overexpression on Liver Cancer in Mice. Technol Cancer Res Treat 2020;19:1533033820942205. [PMID: 33191858 DOI: 10.1177/1533033820942205] [Reference Citation Analysis]
191 Jensen LD, Cao Z, Nakamura M, Yang Y, Bräutigam L, Andersson P, Zhang Y, Wahlberg E, Länne T, Hosaka K, Cao Y. Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish. Cell Rep 2012;2:231-41. [PMID: 22884368 DOI: 10.1016/j.celrep.2012.07.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
192 Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling--are we there yet? Nat Rev Drug Discov. 2014;13:357-378. [PMID: 24781550 DOI: 10.1038/nrd4252] [Cited by in Crossref: 304] [Cited by in F6Publishing: 273] [Article Influence: 38.0] [Reference Citation Analysis]
193 Dong Y, Wu H, Rahman HN, Liu Y, Pasula S, Tessneer KL, Cai X, Liu X, Chang B, McManus J, Hahn S, Dong J, Brophy ML, Yu L, Song K, Silasi-Mansat R, Saunders D, Njoku C, Song H, Mehta-D'Souza P, Towner R, Lupu F, McEver RP, Xia L, Boerboom D, Srinivasan RS, Chen H. Motif mimetic of epsin perturbs tumor growth and metastasis. J Clin Invest 2015;125:4349-64. [PMID: 26571402 DOI: 10.1172/JCI80349] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
194 Dong Y, Wu H, Dong J, Song K, Rahman HA, Towner R, Chen H. Mimetic peptide of ubiquitin-interacting motif of epsin as a cancer therapeutic-perspective in brain tumor therapy through regulating VEGFR2 signaling. Vessel Plus 2017;1:3-11. [PMID: 29905336 DOI: 10.20517/2574-1209.2016.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
195 Purow B. Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol. 2012;727:305-319. [PMID: 22399357 DOI: 10.1007/978-1-4614-0899-4_23] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 10.2] [Reference Citation Analysis]
196 Meisel CT, Porcheri C, Mitsiadis TA. Cancer Stem Cells, Quo Vadis? Cells. 2020;9:1879. [PMID: 32796631 DOI: 10.3390/cells9081879] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
197 van den Akker NM, Caolo V, Molin DG. Cellular decisions in cardiac outflow tract and coronary development: an act by VEGF and NOTCH. Differentiation 2012;84:62-78. [PMID: 22683047 DOI: 10.1016/j.diff.2012.04.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
198 Tung JJ, Tattersall IW, Kitajewski J. Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis. Cold Spring Harb Perspect Med 2012;2:a006601. [PMID: 22355796 DOI: 10.1101/cshperspect.a006601] [Cited by in Crossref: 57] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
199 Jun HT, Stevens J, Kaplan-lefko P. Top NOTCH targets: notch signaling in cancer. Drug Dev Res 2008;69:319-28. [DOI: 10.1002/ddr.20264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
200 Hervieu C, Christou N, Battu S, Mathonnet M. The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials. Cancers (Basel) 2021;13:1092. [PMID: 33806312 DOI: 10.3390/cancers13051092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
201 Strasser GA, Kaminker JS, Tessier-Lavigne M. Microarray analysis of retinal endothelial tip cells identifies CXCR4 as a mediator of tip cell morphology and branching. Blood 2010;115:5102-10. [PMID: 20154215 DOI: 10.1182/blood-2009-07-230284] [Cited by in Crossref: 192] [Cited by in F6Publishing: 174] [Article Influence: 16.0] [Reference Citation Analysis]
202 Zheng W, Tammela T, Yamamoto M, Anisimov A, Holopainen T, Kaijalainen S, Karpanen T, Lehti K, Ylä-Herttuala S, Alitalo K. Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor. Blood 2011;118:1154-62. [PMID: 21566091 DOI: 10.1182/blood-2010-11-317800] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 7.7] [Reference Citation Analysis]
203 Yu J, Siebel CW, Schilling L, Canalis E. An antibody to Notch3 reverses the skeletal phenotype of lateral meningocele syndrome in male mice. J Cell Physiol 2020;235:210-20. [PMID: 31188489 DOI: 10.1002/jcp.28960] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
204 Lord S, Harris AL. Angiogenesis - still a worthwhile target for breast cancer therapy? Breast Cancer Res 2010;12 Suppl 4:S19. [PMID: 21172081 DOI: 10.1186/bcr2748] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
205 Wang MM. Notch signaling and Notch signaling modifiers. Int J Biochem Cell Biol 2011;43:1550-62. [PMID: 21854867 DOI: 10.1016/j.biocel.2011.08.005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
206 Zohny SF, Zamzami MA, Al-Malki AL, Trabulsi NH. Highly Expressed DLL4 and JAG1: Their Role in Incidence of Breast Cancer Metastasis. Arch Med Res 2020;51:145-52. [PMID: 32111499 DOI: 10.1016/j.arcmed.2019.12.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
207 Haller BK, Bråve A, Wallgard E, Roswall P, Sunkari VG, Mattson U, Hallengärd D, Catrina SB, Hellström M, Pietras K. Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma. Oncogene 2010;29:4276-86. [PMID: 20498640 DOI: 10.1038/onc.2010.176] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
208 Stockhausen MT, Kristoffersen K, Poulsen HS. The functional role of Notch signaling in human gliomas. Neuro Oncol 2010;12:199-211. [PMID: 20150387 DOI: 10.1093/neuonc/nop022] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
209 Quillard T, Devallière J, Coupel S, Charreau B. Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. Biochem Pharmacol 2010;80:2032-41. [PMID: 20643108 DOI: 10.1016/j.bcp.2010.07.010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
210 Abbas OL, Terzi YK, Özatik O, Özatik FY, Turna G, Nar R, Musmul A. Enhancement of vascular endothelial growth factor's angiogenic capacity by the therapeutic modulation of notch signalling improves tram flap survival in rats submitted to nicotine. J Plast Surg Hand Surg 2017;51:405-13. [PMID: 28277073 DOI: 10.1080/2000656X.2017.1285784] [Reference Citation Analysis]
211 Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer 2017;17:145-59. [PMID: 28154375 DOI: 10.1038/nrc.2016.145] [Cited by in Crossref: 173] [Cited by in F6Publishing: 163] [Article Influence: 34.6] [Reference Citation Analysis]
212 Hada K, Suda A, Asoh K, Tsukuda T, Hasegawa M, Sato Y, Ogawa K, Kuramoto S, Aoki Y, Shimma N, Ishikawa T, Koyano H. Angiogenesis inhibitors identified by cell-based high-throughput screening: synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation. Bioorg Med Chem 2012;20:1442-60. [PMID: 22269278 DOI: 10.1016/j.bmc.2011.12.058] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
213 Zhang JX, Cai MB, Wang XP, Duan LP, Shao Q, Tong ZT, Liao DZ, Li YY, Huang MY, Zeng YX, Shao JY. Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma. Med Oncol 2013;30:390. [PMID: 23275120 DOI: 10.1007/s12032-012-0390-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
214 Radojcic V, Paz K, Chung J, Du J, Perkey ET, Flynn R, Ivcevic S, Zaiken M, Friedman A, Yan M, Pletneva MA, Sarantopoulos S, Siebel CW, Blazar BR, Maillard I. Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice. Blood 2018;132:2188-200. [PMID: 30181175 DOI: 10.1182/blood-2018-03-841155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
215 El Hindy N, Keyvani K, Pagenstecher A, Dammann P, Sandalcioglu IE, Sure U, Zhu Y. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. Neuro Oncol 2013;15:1366-78. [PMID: 23787764 DOI: 10.1093/neuonc/not071] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
216 Boscolo E, Stewart CL, Greenberger S, Wu JK, Durham JT, Herman IM, Mulliken JB, Kitajewski J, Bischoff J. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 2011;31:2181-92. [PMID: 21757656 DOI: 10.1161/ATVBAHA.111.232934] [Cited by in Crossref: 50] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
217 Zhu AX, Duda DG, Sahani DV, Jain RK. HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol 2011;8:292-301. [PMID: 21386818 DOI: 10.1038/nrclinonc.2011.30] [Cited by in Crossref: 293] [Cited by in F6Publishing: 302] [Article Influence: 26.6] [Reference Citation Analysis]
218 Wu Q, Wang X. Neuronal stem cells in the central nervous system and in human diseases. Protein Cell 2012;3:262-70. [PMID: 22528753 DOI: 10.1007/s13238-012-2930-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
219 Schadler KL, Zweidler-McKay PA, Guan H, Kleinerman ES. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma. Clin Cancer Res 2010;16:848-56. [PMID: 20103680 DOI: 10.1158/1078-0432.CCR-09-1299] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
220 Liu H, Mei FC, Yang W, Wang H, Wong E, Cai J, Toth E, Luo P, Li YM, Zhang W, Cheng X. Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling. Sci Adv 2020;6:eaay3566. [PMID: 31911948 DOI: 10.1126/sciadv.aay3566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
221 Lee D, Kim D, Choi YB, Kang K, Sung ES, Ahn JH, Goo J, Yeom DH, Jang HS, Moon KD, Lee SH, You WK. Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis. MAbs 2016;8:892-904. [PMID: 27049350 DOI: 10.1080/19420862.2016.1171432] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
222 Poulet M, Sirois J, Boyé K, Uetani N, Hardy S, Daubon T, Dubrac A, Tremblay ML, Bikfalvi A. PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling. Commun Biol 2020;3:603. [PMID: 33097786 DOI: 10.1038/s42003-020-01343-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
223 Pellegrinet L, Rodilla V, Liu Z, Chen S, Koch U, Espinosa L, Kaestner KH, Kopan R, Lewis J, Radtke F. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Gastroenterology. 2011;140:1230-1240.e1-7. [PMID: 21238454 DOI: 10.1053/j.gastro.2011.01.005] [Cited by in Crossref: 256] [Cited by in F6Publishing: 250] [Article Influence: 23.3] [Reference Citation Analysis]
224 Gerritsen ME. Angiogenesis. Microcirculation. Elsevier; 2008. pp. 351-83. [DOI: 10.1016/b978-0-12-374530-9.00008-5] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
225 Andrawes MB, Xu X, Liu H, Ficarro SB, Marto JA, Aster JC, Blacklow SC. Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1. J Biol Chem 2013;288:25477-89. [PMID: 23839946 DOI: 10.1074/jbc.M113.454850] [Cited by in Crossref: 84] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
226 Yang Z, Jiang S, Cheng Y, Li T, Hu W, Ma Z, Chen F, Yang Y. FOXC1 in cancer development and therapy: Deciphering its emerging and divergent roles. Ther Adv Med Oncol. 2017;9:797-816. [PMID: 29449899 DOI: 10.1177/1758834017742576] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
227 Flores AN, McDermott N, Meunier A, Marignol L. NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer. Nat Rev Urol 2014;11:499-507. [PMID: 25134838 DOI: 10.1038/nrurol.2014.195] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
228 Hu XB, Feng F, Wang YC, Wang L, He F, Dou GR, Liang L, Zhang HW, Liang YM, Han H. Blockade of Notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types. Neoplasia 2009;11:32-8. [PMID: 19107229 DOI: 10.1593/neo.81008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
229 Sherry KP, Johnson SE, Hatem CL, Majumdar A, Barrick D. Effects of Linker Length and Transient Secondary Structure Elements in the Intrinsically Disordered Notch RAM Region on Notch Signaling. J Mol Biol 2015;427:3587-97. [PMID: 26344835 DOI: 10.1016/j.jmb.2015.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
230 Bohin N, Keeley TM, Carulli AJ, Walker EM, Carlson EA, Gao J, Aifantis I, Siebel CW, Rajala MW, Myers MG Jr, Jones JC, Brindley CD, Dempsey PJ, Samuelson LC. Rapid Crypt Cell Remodeling Regenerates the Intestinal Stem Cell Niche after Notch Inhibition. Stem Cell Reports 2020;15:156-70. [PMID: 32531190 DOI: 10.1016/j.stemcr.2020.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
231 Brzozowa M, Wojnicz R, Kowalczyk-Ziomek G, Helewski K. The Notch ligand Delta-like 4 (DLL4) as a target in angiogenesis-based cancer therapy? Contemp Oncol (Pozn) 2013;17:234-7. [PMID: 24596507 DOI: 10.5114/wo.2013.35588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
232 Koch U, Radtke F. Notch signaling in solid tumors. Curr Top Dev Biol. 2010;92:411-455. [PMID: 20816403 DOI: 10.1016/s0070-2153(10)92013-9] [Cited by in Crossref: 82] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
233 Fournier P, Viallard C, Dejda A, Sapieha P, Larrivée B, Royal I. The protein tyrosine phosphatase PTPRJ/DEP-1 contributes to the regulation of the Notch-signaling pathway and sprouting angiogenesis. Angiogenesis 2020;23:145-57. [DOI: 10.1007/s10456-019-09683-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
234 Charles N, Holland EC. The perivascular niche microenvironment in brain tumor progression. Cell Cycle 2010;9:3012-21. [PMID: 20714216 DOI: 10.4161/cc.9.15.12710] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 8.7] [Reference Citation Analysis]
235 Murakami N, Maillard I, Riella LV. Notch Signaling and Immune Regulation in Alloimmunity. Curr Transplant Rep 2016;3:294-302. [PMID: 29977738 DOI: 10.1007/s40472-016-0126-5] [Reference Citation Analysis]
236 Cullion K, Draheim KM, Hermance N, Tammam J, Sharma VM, Ware C, Nikov G, Krishnamoorthy V, Majumder PK, Kelliher MA. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. Blood 2009;113:6172-81. [PMID: 19246562 DOI: 10.1182/blood-2008-02-136762] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 8.5] [Reference Citation Analysis]
237 Yao Y, Ni Y, Zhang J, Wang H, Shao S. The role of Notch signaling in gastric carcinoma: molecular pathogenesis and novel therapeutic targets. Oncotarget 2017;8:53839-53. [PMID: 28881855 DOI: 10.18632/oncotarget.17809] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
238 Ferreira A, Aster JC. Notch signaling in cancer: Complexity and challenges on the path to clinical translation. Semin Cancer Biol 2021:S1044-579X(21)00109-7. [PMID: 33862222 DOI: 10.1016/j.semcancer.2021.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
239 Gerhardt H. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 2008;4:241-6. [PMID: 19337404 DOI: 10.4161/org.4.4.7414] [Cited by in Crossref: 162] [Cited by in F6Publishing: 153] [Article Influence: 16.2] [Reference Citation Analysis]
240 Zheng Y, Wang S, Xue X, Xu A, Liao W, Deng A, Dai G, Liu AP, Fu J. Notch signaling in regulating angiogenesis in a 3D biomimetic environment. Lab Chip 2017;17:1948-59. [PMID: 28470301 DOI: 10.1039/c7lc00186j] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
241 Chan J, Mably JD. Dissection of cardiovascular development and disease pathways in zebrafish. Prog Mol Biol Transl Sci 2011;100:111-53. [PMID: 21377626 DOI: 10.1016/B978-0-12-384878-9.00004-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
242 Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-78. [PMID: 17522591 DOI: 10.1038/nrm2183] [Cited by in Crossref: 1278] [Cited by in F6Publishing: 1180] [Article Influence: 85.2] [Reference Citation Analysis]
243 Fortini F, Vieceli Dalla Sega F, Caliceti C, Lambertini E, Pannuti A, Peiffer DS, Balla C, Rizzo P. Estrogen-mediated protection against coronary heart disease: The role of the Notch pathway. J Steroid Biochem Mol Biol 2019;189:87-100. [PMID: 30817989 DOI: 10.1016/j.jsbmb.2019.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
244 Xiao M, Yang S, Ning X, Huang Y. Aberrant expression of δ-like ligand 4 contributes significantly to axillary lymph node metastasis and predicts postoperative outcome in breast cancer. Hum Pathol 2014;45:2302-10. [PMID: 25260720 DOI: 10.1016/j.humpath.2014.04.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
245 Biel NM, Siemann DW. Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference. Cancer Lett 2016;380:525-33. [PMID: 25312939 DOI: 10.1016/j.canlet.2014.09.035] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
246 Duran CL, Howell DW, Dave JM, Smith RL, Torrie ME, Essner JJ, Bayless KJ. Molecular Regulation of Sprouting Angiogenesis. Compr Physiol 2017;8:153-235. [PMID: 29357127 DOI: 10.1002/cphy.c160048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
247 Cai WX, Liang L, Wang L, Han JT, Zhu XX, Han H, Hu DH, Zhang P. Inhibition of Notch signaling leads to increased intracellular ROS by up-regulating Nox4 expression in primary HUVECs. Cell Immunol 2014;287:129-35. [PMID: 24491913 DOI: 10.1016/j.cellimm.2013.12.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
248 Swift MR, Weinstein BM. Arterial-venous specification during development. Circ Res 2009;104:576-88. [PMID: 19286613 DOI: 10.1161/CIRCRESAHA.108.188805] [Cited by in Crossref: 275] [Cited by in F6Publishing: 169] [Article Influence: 21.2] [Reference Citation Analysis]
249 Xu R, Shimizu F, Hovinga K, Beal K, Karimi S, Droms L, Peck KK, Gutin P, Iorgulescu JB, Kaley T, DeAngelis L, Pentsova E, Nolan C, Grommes C, Chan T, Bobrow D, Hormigo A, Cross JR, Wu N, Takebe N, Panageas K, Ivy P, Supko JG, Tabar V, Omuro A. Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial. Clin Cancer Res 2016;22:4786-96. [PMID: 27154916 DOI: 10.1158/1078-0432.CCR-16-0048] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
250 Coleman RL, Handley KF, Burger R, Molin GZD, Stagg R, Sood AK, Moore KN. Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trial. Gynecol Oncol 2020;157:386-91. [PMID: 32037195 DOI: 10.1016/j.ygyno.2020.01.042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
251 Li JL, Jubb AM, Harris AL. Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity. Future Oncol 2010;6:1099-103. [PMID: 20624122 DOI: 10.2217/fon.10.62] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
252 Glomski K, Monette S, Manova K, De Strooper B, Saftig P, Blobel CP. Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures. Blood 2011;118:1163-74. [PMID: 21652679 DOI: 10.1182/blood-2011-04-348557] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
253 Kim WY, Lee HY. Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors. FEBS J 2009;276:4653-64. [PMID: 19664069 DOI: 10.1111/j.1742-4658.2009.07177.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
254 Ryeom SW. The cautionary tale of side effects of chronic Notch1 inhibition. J Clin Invest 2011;121:508-9. [DOI: 10.1172/jci45976] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
255 Rama N, Dubrac A, Mathivet T, Ní Chárthaigh RA, Genet G, Cristofaro B, Pibouin-Fragner L, Ma L, Eichmann A, Chédotal A. Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization. Nat Med 2015;21:483-91. [PMID: 25894826 DOI: 10.1038/nm.3849] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 14.0] [Reference Citation Analysis]
256 Bridge G, Monteiro R, Henderson S, Emuss V, Lagos D, Georgopoulou D, Patient R, Boshoff C. The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood. 2012;120:5063-5072. [PMID: 23086751 DOI: 10.1182/blood-2012-04-423004] [Cited by in Crossref: 123] [Cited by in F6Publishing: 117] [Article Influence: 12.3] [Reference Citation Analysis]
257 Thurston G, Noguera-Troise I, Yancopoulos GD. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer. 2007;7:327-331. [PMID: 17457300 DOI: 10.1038/nrc2130] [Cited by in Crossref: 211] [Cited by in F6Publishing: 205] [Article Influence: 14.1] [Reference Citation Analysis]
258 Chi L, Ahmed A, Roy AR, Vuong S, Cahill LS, Caporiccio L, Sled JG, Caniggia I, Wilson MD, Delgado-olguin P. Ehmt2/G9a controls placental vascular maturation by activating the Notch pathway. Development. [DOI: 10.1242/dev.148916] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
259 Holderfield MT, Hughes CC. Crosstalk Between Vascular Endothelial Growth Factor, Notch, and Transforming Growth Factor-β in Vascular Morphogenesis. Circulation Research 2008;102:637-52. [DOI: 10.1161/circresaha.107.167171] [Cited by in Crossref: 231] [Cited by in F6Publishing: 126] [Article Influence: 16.5] [Reference Citation Analysis]
260 Zhang X, Meng H, Wang MM. Collagen represses canonical Notch signaling and binds to Notch ectodomain. Int J Biochem Cell Biol 2013;45:1274-80. [PMID: 23579095 DOI: 10.1016/j.biocel.2013.03.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
261 Mancarella S, Serino G, Dituri F, Cigliano A, Ribback S, Wang J, Chen X, Calvisi DF, Giannelli G. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis. Cell Death Differ. 2020;27:2330-2343. [PMID: 32042099 DOI: 10.1038/s41418-020-0505-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
262 Falcon BL, Swearingen M, Gough WH, Lee L, Foreman R, Uhlik M, Hanson JC, Lee JA, McClure DB, Chintharlapalli S. An in vitro cord formation assay identifies unique vascular phenotypes associated with angiogenic growth factors. PLoS One 2014;9:e106901. [PMID: 25210890 DOI: 10.1371/journal.pone.0106901] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
263 Masuda S, Kumano K, Suzuki T, Tomita T, Iwatsubo T, Natsugari H, Tojo A, Shibutani M, Mitsumori K, Hanazono Y, Ogawa S, Kurokawa M, Chiba S. Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model. Cancer Science 2009;100:2444-50. [DOI: 10.1111/j.1349-7006.2009.01328.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
264 Mitsuhashi Y, Horiuchi A, Miyamoto T, Kashima H, Suzuki A, Shiozawa T. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells. Histopathology. 2012;60:826-837. [PMID: 22348356 DOI: 10.1111/j.1365-2559.2011.04158.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
265 Xue Y, Cao R, Nilsson D, Chen S, Westergren R, Hedlund EM, Martijn C, Rondahl L, Krauli P, Walum E, Enerbäck S, Cao Y. FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proc Natl Acad Sci U S A 2008;105:10167-72. [PMID: 18621714 DOI: 10.1073/pnas.0802486105] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 5.4] [Reference Citation Analysis]
266 Roukens MG, Alloul-Ramdhani M, Baan B, Kobayashi K, Peterson-Maduro J, van Dam H, Schulte-Merker S, Baker DA. Control of endothelial sprouting by a Tel-CtBP complex. Nat Cell Biol 2010;12:933-42. [PMID: 20835243 DOI: 10.1038/ncb2096] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
267 Goldman SA, Chen Z. Perivascular instruction of cell genesis and fate in the adult brain. Nat Neurosci. 2011;14:1382-1389. [PMID: 22030549 DOI: 10.1038/nn.2963] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 9.2] [Reference Citation Analysis]
268 Müller R, Kömhoff M, Peters JM, Müller-Brüsselbach S. A Role for PPARbeta/delta in Tumor Stroma and Tumorigenesis. PPAR Res 2008;2008:534294. [PMID: 18497874 DOI: 10.1155/2008/534294] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
269 Baharlou R, Tajik N, Behdani M, Shokrgozar MA, Tavana V, Kazemi-lomedasht F, Faraji F, Habibi-anbouhi M. An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization. Immunopharmacology and Immunotoxicology 2018;40:368-74. [DOI: 10.1080/08923973.2018.1505907] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
270 Loges S, Schmidt T, Carmeliet P. Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates. Genes Cancer 2010;1:12-25. [PMID: 21779425 DOI: 10.1177/1947601909356574] [Cited by in Crossref: 181] [Cited by in F6Publishing: 174] [Article Influence: 16.5] [Reference Citation Analysis]
271 Djokovic D, Trindade A, Gigante J, Pinho M, Harris AL, Duarte A. Incomplete Dll4/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas. BMC Cancer 2015;15:608. [PMID: 26314892 DOI: 10.1186/s12885-015-1605-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
272 Sharma G, Jagtap JM, Parchur AK, Gogineni VR, Ran S, Bergom C, White SB, Flister MJ, Joshi A. Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy. Theranostics 2020;10:5368-83. [PMID: 32373218 DOI: 10.7150/thno.41171] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
273 De Biasio A, Guarnaccia C, Popovic M, Uversky VN, Pintar A, Pongor S. Prevalence of intrinsic disorder in the intracellular region of human single-pass type I proteins: the case of the notch ligand Delta-4. J Proteome Res 2008;7:2496-506. [PMID: 18435556 DOI: 10.1021/pr800063u] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
274 Kuhnert F, Kirshner JR, Thurston G. Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vasc Cell. 2011;3:20. [PMID: 21923938 DOI: 10.1186/2045-824x-3-20] [Cited by in Crossref: 79] [Cited by in F6Publishing: 55] [Article Influence: 7.2] [Reference Citation Analysis]
275 Steeg PS, Theodorescu D. Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol. 2008;5:206-219. [PMID: 18253104 DOI: 10.1038/ncponc1066] [Cited by in Crossref: 234] [Cited by in F6Publishing: 214] [Article Influence: 16.7] [Reference Citation Analysis]
276 Albig AR, Becenti DJ, Roy TG, Schiemann WP. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc Res 2008;76:7-14. [PMID: 18417156 DOI: 10.1016/j.mvr.2008.01.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
277 Abbas OL, Borman H, Terzi YK, Terzi A, Bayraktar N, Özkan B, Yazici AC. Inhibition of the Notch Pathway Promotes Flap Survival by Inducing Functional Neoangiogenesis. Annals of Plastic Surgery 2015;75:455-62. [DOI: 10.1097/sap.0000000000000197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
278 Sennino B, McDonald DM. Controlling escape from angiogenesis inhibitors. Nat Rev Cancer 2012;12:699-709. [PMID: 23001349 DOI: 10.1038/nrc3366] [Cited by in Crossref: 172] [Cited by in F6Publishing: 166] [Article Influence: 17.2] [Reference Citation Analysis]
279 Zoller F, Markert A, Barthe P, Zhao W, Weichert W, Askoxylakis V, Altmann A, Mier W, Haberkorn U. Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor-Targeting Miniproteins. Angew Chem 2012;124:13313-6. [DOI: 10.1002/ange.201203857] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
280 Mitchell DC, Bryan BA. Anti-angiogenic therapy: adapting strategies to overcome resistant tumors. J Cell Biochem 2010;111:543-53. [PMID: 20626031 DOI: 10.1002/jcb.22764] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
281 Alabi RO, Farber G, Blobel CP. Intriguing Roles for Endothelial ADAM10/Notch Signaling in the Development of Organ-Specific Vascular Beds. Physiol Rev 2018;98:2025-61. [PMID: 30067156 DOI: 10.1152/physrev.00029.2017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
282 Nagasaka M, Taniguchi-Ikeda M, Inagaki H, Ouchi Y, Kurokawa D, Yamana K, Harada R, Nozu K, Sakai Y, Mishra SK, Yamaguchi Y, Morioka I, Toda T, Kurahashi H, Iijima K. Novel missense mutation in DLL4 in a Japanese sporadic case of Adams-Oliver syndrome. J Hum Genet 2017;62:851-5. [PMID: 28446798 DOI: 10.1038/jhg.2017.48] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
283 Ding XY, Ding J, Wu K, Wen W, Liu C, Yan HX, Chen C, Wang S, Tang H, Gao CK. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Oncogene. 2012;31:2899-2906. [PMID: 22002304 DOI: 10.1038/onc.2011.467] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
284 Ruppel J, Brady A, Elliott R, Leddy C, Palencia M, Coleman D, Couch JA, Wakshull E. Preexisting Antibodies to an F(ab')2 Antibody Therapeutic and Novel Method for Immunogenicity Assessment. J Immunol Res 2016;2016:2921758. [PMID: 27413757 DOI: 10.1155/2016/2921758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
285 Colombo M, Mirandola L, Chiriva-Internati M, Basile A, Locati M, Lesma E, Chiaramonte R, Platonova N. Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu. Front Immunol. 2018;9:1823. [PMID: 30154786 DOI: 10.3389/fimmu.2018.01823] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
286 Emuss V, Lagos D, Pizzey A, Gratrix F, Henderson SR, Boshoff C. KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog. 2009;5:e1000616. [PMID: 19816565 DOI: 10.1371/journal.ppat.1000616] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
287 Warren CM, Iruela-Arispe ML. Signaling circuitry in vascular morphogenesis. Curr Opin Hematol 2010;17:213-8. [PMID: 20216211 DOI: 10.1097/MOH.0b013e32833865d1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
288 Segarra M, Williams CK, Sierra Mde L, Bernardo M, McCormick PJ, Maric D, Regino C, Choyke P, Tosato G. Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood 2008;112:1904-11. [PMID: 18577711 DOI: 10.1182/blood-2007-11-126045] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
289 Cao Y. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis. Trends Mol Med 2013;19:460-73. [PMID: 23773831 DOI: 10.1016/j.molmed.2013.05.002] [Cited by in Crossref: 105] [Cited by in F6Publishing: 105] [Article Influence: 11.7] [Reference Citation Analysis]
290 Tetzlaff F, Fischer A. Control of Blood Vessel Formation by Notch Signaling. Adv Exp Med Biol 2018;1066:319-38. [PMID: 30030834 DOI: 10.1007/978-3-319-89512-3_16] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
291 Red-Horse K, Siekmann AF. Veins and Arteries Build Hierarchical Branching Patterns Differently: Bottom-Up versus Top-Down. Bioessays 2019;41:e1800198. [PMID: 30805984 DOI: 10.1002/bies.201800198] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
292 Gridley T. Vessel guidance. Nature 2007;445:722-3. [DOI: 10.1038/445722a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
293 Sugimoto K, Maekawa Y, Kitamura A, Nishida J, Koyanagi A, Yagita H, Kojima H, Chiba S, Shimada M, Yasutomo K. Notch2 signaling is required for potent antitumor immunity in vivo. J Immunol 2010;184:4673-8. [PMID: 20351182 DOI: 10.4049/jimmunol.0903661] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
294 Jimeno A, Moore KN, Gordon M, Chugh R, Diamond JR, Aljumaily R, Mendelson D, Kapoun AM, Xu L, Stagg R, Smith DC. A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors. Invest New Drugs 2019;37:461-72. [PMID: 30229512 DOI: 10.1007/s10637-018-0665-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
295 Jarzabek MA, Proctor WR, Vogt J, Desai R, Dicker P, Cain G, Raja R, Brodbeck J, Stevens D, van der Stok EP, Martens JWM, Verhoef C, Hegde PS, Byrne AT, Tarrant JM. Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer. PLoS One 2018;13:e0198099. [PMID: 29879147 DOI: 10.1371/journal.pone.0198099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
296 Tetzlaff F, Adam MG, Feldner A, Moll I, Menuchin A, Rodriguez-Vita J, Sprinzak D, Fischer A. MPDZ promotes DLL4-induced Notch signaling during angiogenesis. Elife 2018;7:e32860. [PMID: 29620522 DOI: 10.7554/eLife.32860] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
297 Canalis E, Sanjay A, Yu J, Zanotti S. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice. Endocrinology 2017;158:730-42. [PMID: 28323963 DOI: 10.1210/en.2016-1787] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
298 Carmeliet P, De Smet F, Loges S, Mazzone M. Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat Rev Clin Oncol 2009;6:315-26. [DOI: 10.1038/nrclinonc.2009.64] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 10.8] [Reference Citation Analysis]
299 Selvam S, Kumar T, Fruttiger M. Retinal vasculature development in health and disease. Prog Retin Eye Res 2018;63:1-19. [PMID: 29129724 DOI: 10.1016/j.preteyeres.2017.11.001] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 17.8] [Reference Citation Analysis]
300 Al Haj Zen A, Oikawa A, Bazan-Peregrino M, Meloni M, Emanueli C, Madeddu P. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Circ Res 2010;107:283-93. [PMID: 20508179 DOI: 10.1161/CIRCRESAHA.110.221663] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
301 Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol. 2012;181:1126-1141. [PMID: 22858156 DOI: 10.1016/j.ajpath.2012.06.030] [Cited by in Crossref: 261] [Cited by in F6Publishing: 231] [Article Influence: 26.1] [Reference Citation Analysis]
302 Chappell JC, Darden J, Payne LB, Fink K, Bautch VL. Blood Vessel Patterning on Retinal Astrocytes Requires Endothelial Flt-1 (VEGFR-1). J Dev Biol 2019;7:E18. [PMID: 31500294 DOI: 10.3390/jdb7030018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
303 De Bock K, De Smet F, Leite De Oliveira R, Anthonis K, Carmeliet P. Endothelial oxygen sensors regulate tumor vessel abnormalization by instructing phalanx endothelial cells. J Mol Med (Berl) 2009;87:561-9. [PMID: 19455291 DOI: 10.1007/s00109-009-0482-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
304 Dhanabal M, Karumanchi SA, Sukhatme VP. Targeting tumor vascular endothelium: an emerging concept for cancer therapy. Drug Dev Res 2008;69:340-51. [DOI: 10.1002/ddr.20266] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
305 Zhao XC, Dou GR, Wang L, Liang L, Tian DM, Cao XL, Qin HY, Wang CM, Zhang P, Han H. Inhibition of tumor angiogenesis and tumor growth by the DSL domain of human Delta-like 1 targeted to vascular endothelial cells. Neoplasia 2013;15:815-25. [PMID: 23814493 DOI: 10.1593/neo.13550] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
306 Rhee S, Chung JI, King DA, D'amato G, Paik DT, Duan A, Chang A, Nagelberg D, Sharma B, Jeong Y, Diehn M, Wu JC, Morrison AJ, Red-Horse K. Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease. Nat Commun 2018;9:368. [PMID: 29371594 DOI: 10.1038/s41467-017-02796-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
307 Sakurai Y, Hada T, Kato A, Hagino Y, Mizumura W, Harashima H. Effective Therapy Using a Liposomal siRNA that Targets the Tumor Vasculature in a Model Murine Breast Cancer with Lung Metastasis. Mol Ther Oncolytics 2018;11:102-8. [PMID: 30534584 DOI: 10.1016/j.omto.2018.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
308 Silva EA, Kim ES, Kong HJ, Mooney DJ. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A 2008;105:14347-52. [PMID: 18794520 DOI: 10.1073/pnas.0803873105] [Cited by in Crossref: 167] [Cited by in F6Publishing: 144] [Article Influence: 11.9] [Reference Citation Analysis]
309 Chappell JC, Cluceru JG, Nesmith JE, Mouillesseaux KP, Bradley VB, Hartland CM, Hashambhoy-Ramsay YL, Walpole J, Peirce SM, Mac Gabhann F, Bautch VL. Flt-1 (VEGFR-1) coordinates discrete stages of blood vessel formation. Cardiovasc Res 2016;111:84-93. [PMID: 27142980 DOI: 10.1093/cvr/cvw091] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
310 Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol. 2008;10:254-264. [PMID: 18359864 DOI: 10.1215/15228517-2008-001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
311 Haas TL, Lloyd PG, Yang HT, Terjung RL. Exercise training and peripheral arterial disease. Compr Physiol 2012;2:2933-3017. [PMID: 23720270 DOI: 10.1002/cphy.c110065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
312 Fukuda D, Aikawa E, Swirski FK, Novobrantseva TI, Kotelianski V, Gorgun CZ, Chudnovskiy A, Yamazaki H, Croce K, Weissleder R, Aster JC, Hotamisligil GS, Yagita H, Aikawa M. Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci U S A 2012;109:E1868-77. [PMID: 22699504 DOI: 10.1073/pnas.1116889109] [Cited by in Crossref: 107] [Cited by in F6Publishing: 104] [Article Influence: 10.7] [Reference Citation Analysis]
313 Bentley K, Chakravartula S. The temporal basis of angiogenesis. Philos Trans R Soc Lond B Biol Sci 2017;372:20150522. [PMID: 28348255 DOI: 10.1098/rstb.2015.0522] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
314 De Smet F, Segura I, De Bock K, Hohensinner PJ, Carmeliet P. Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way. ATVB 2009;29:639-49. [DOI: 10.1161/atvbaha.109.185165] [Cited by in Crossref: 248] [Cited by in F6Publishing: 140] [Article Influence: 19.1] [Reference Citation Analysis]
315 Wang L, Jin Z, Wang J, Chen S, Dai L, Lin D, Wu L, Gao W. Detrimental effect of Hypoxia-inducible factor-1α-induced autophagy on multiterritory perforator flap survival in rats. Sci Rep 2017;7:11791. [PMID: 28924179 DOI: 10.1038/s41598-017-12034-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
316 Hermann DM, Buga AM, Popa-Wagner A. Neurovascular remodeling in the aged ischemic brain. J Neural Transm (Vienna) 2015;122 Suppl 1:S25-33. [PMID: 24378703 DOI: 10.1007/s00702-013-1148-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
317 Lu J, Xia Y, Chen K, Zheng Y, Wang J, Lu W, Yin Q, Wang F, Zhou Y, Guo C. Oncogenic role of the Notch pathway in primary liver cancer. Oncol Lett. 2016;12:3-10. [PMID: 27347091 DOI: 10.3892/ol.2016.4609] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
318 Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood 2008;112:1720-9. [PMID: 18559979 DOI: 10.1182/blood-2007-09-112748] [Cited by in Crossref: 94] [Cited by in F6Publishing: 88] [Article Influence: 6.7] [Reference Citation Analysis]
319 Minuzzo S, Agnusdei V, Pusceddu I, Pinazza M, Moserle L, Masiero M, Rossi E, Crescenzi M, Hoey T, Ponzoni M, Amadori A, Indraccolo S. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice. Carcinogenesis 2015;36:115-21. [PMID: 25355291 DOI: 10.1093/carcin/bgu223] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
320 Liu Z, Turkoz A, Jackson EN, Corbo JC, Engelbach JA, Garbow JR, Piwnica-Worms DR, Kopan R. Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice. J Clin Invest 2011;121:800-8. [PMID: 21266774 DOI: 10.1172/JCI43114] [Cited by in Crossref: 90] [Cited by in F6Publishing: 65] [Article Influence: 8.2] [Reference Citation Analysis]
321 Soumya S, Athira A, Binu S, Sudhakaran P. mTOR as a Modulator of Metabolite Sensing Relevant to Angiogenesis. Molecules to Medicine with mTOR. Elsevier; 2016. pp. 229-43. [DOI: 10.1016/b978-0-12-802733-2.00014-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
322 Costa MJ, Wu X, Cuervo H, Srinivasan R, Bechis SK, Cheang E, Marjanovic O, Gridley T, Cvetic CA, Wang RA. Notch4 is required for tumor onset and perfusion. Vasc Cell 2013;5:7. [PMID: 23601498 DOI: 10.1186/2045-824X-5-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
323 Klose R, Berger C, Moll I, Adam MG, Schwarz F, Mohr K, Augustin HG, Fischer A. Soluble Notch ligand and receptor peptides act antagonistically during angiogenesis. Cardiovasc Res 2015;107:153-63. [PMID: 25975260 DOI: 10.1093/cvr/cvv151] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
324 Wang W, McKinnie SM, Patel VB, Haddad G, Wang Z, Zhabyeyev P, Das SK, Basu R, McLean B, Kandalam V, Penninger JM, Kassiri Z, Vederas JC, Murray AG, Oudit GY. Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues. J Am Heart Assoc 2013;2:e000249. [PMID: 23817469 DOI: 10.1161/JAHA.113.000249] [Cited by in Crossref: 107] [Cited by in F6Publishing: 62] [Article Influence: 11.9] [Reference Citation Analysis]
325 Reinacher-Schick A, Pohl M, Schmiegel W. Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies. Nat Clin Pract Gastroenterol Hepatol 2008;5:250-67. [PMID: 18382435 DOI: 10.1038/ncpgasthep1097] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
326 Ziyad S, Iruela-Arispe ML. Molecular mechanisms of tumor angiogenesis. Genes Cancer. 2011;2:1085-1096. [PMID: 22866200 DOI: 10.1177/1947601911432334] [Cited by in Crossref: 101] [Cited by in F6Publishing: 98] [Article Influence: 10.1] [Reference Citation Analysis]
327 Choi I, Lee S, Hong YK. The new era of the lymphatic system: no longer secondary to the blood vascular system. Cold Spring Harb Perspect Med 2012;2:a006445. [PMID: 22474611 DOI: 10.1101/cshperspect.a006445] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 7.9] [Reference Citation Analysis]
328 Pedrosa AR, Trindade A, Carvalho C, Graça J, Carvalho S, Peleteiro MC, Adams RH, Duarte A. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions. Oncotarget 2015;6:24404-23. [PMID: 26213336 DOI: 10.18632/oncotarget.4380] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
329 Shojaei F, Ferrara N. Antiangiogenic therapy for cancer: an update. Cancer J. 2007;13:345-348. [PMID: 18032969 DOI: 10.1097/PPO.0b013e31815a7b69] [Cited by in Crossref: 51] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
330 Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, Blades J, Li JL, Allen P, Leek R. Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol. 2010;176:2019-2028. [PMID: 20167860 DOI: 10.2353/ajpath.2010.090908] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 6.4] [Reference Citation Analysis]
331 Mahon CM, Lambert MA, Glanville J, Wade JM, Fennell BJ, Krebs MR, Armellino D, Yang S, Liu X, O'sullivan CM, Autin B, Oficjalska K, Bloom L, Paulsen J, Gill D, Damelin M, Cunningham O, Finlay WJ. Comprehensive Interrogation of a Minimalist Synthetic CDR-H3 Library and Its Ability to Generate Antibodies with Therapeutic Potential. Journal of Molecular Biology 2013;425:1712-30. [DOI: 10.1016/j.jmb.2013.02.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
332 Cao Y, Zhong W, Sun Y. Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance. Seminars in Cancer Biology 2009;19:338-43. [DOI: 10.1016/j.semcancer.2009.05.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
333 El Kaffas A, Nofiele J, Giles A, Cho S, Liu SK, Czarnota GJ. Dll4-notch signalling blockade synergizes combined ultrasound-stimulated microbubble and radiation therapy in human colon cancer xenografts. PLoS One 2014;9:e93888. [PMID: 24736631 DOI: 10.1371/journal.pone.0093888] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
334 Meng H, Zhang X, Yu G, Lee SJ, Chen YE, Prudovsky I, Wang MM. Biochemical characterization and cellular effects of CADASIL mutants of NOTCH3. PLoS One 2012;7:e44964. [PMID: 23028706 DOI: 10.1371/journal.pone.0044964] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
335 Bridges E, Oon CE, Harris A. Notch regulation of tumor angiogenesis. Future Oncol 2011;7:569-88. [PMID: 21463145 DOI: 10.2217/fon.11.20] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
336 Fabian KP, Chi-Sabins N, Taylor JL, Fecek R, Weinstein A, Storkus WJ. Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice. Oncoimmunology 2017;6:e1290035. [PMID: 28405524 DOI: 10.1080/2162402X.2017.1290035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
337 Broxterman HJ, Georgopapadakou NH. Anticancer therapeutics: A surge of new developments increasingly target tumor and stroma. Drug Resistance Updates 2007;10:182-93. [DOI: 10.1016/j.drup.2007.07.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
338 Xuan S, Shin DH, Kim J. Angiopep-2-conjugated liposomes encapsulating γ-secretase inhibitor for targeting glioblastoma stem cells. Journal of Pharmaceutical Investigation 2014;44:473-83. [DOI: 10.1007/s40005-014-0151-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
339 Badenes M, Trindade A, Pissarra H, Lopes-da-Costa L, Duarte A. Delta-like 4/Notch signaling promotes Apc Min/+ tumor initiation through angiogenic and non-angiogenic related mechanisms. BMC Cancer 2017;17:50. [PMID: 28086833 DOI: 10.1186/s12885-016-3036-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
340 Hicklin DJ. Promoting angiogenesis to a fault. Nat Biotechnol 2007;25:300-2. [DOI: 10.1038/nbt0307-300] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
341 Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, Schahin-Reed D, Dow GJ, Shelton A, Stawicki S, Watts RJ, Zhang J, Choy R, Howard P, Kadyk L, Yan M, Zha J, Callahan CA, Hymowitz SG, Siebel CW. Therapeutic antibody targeting of individual Notch receptors. Nature. 2010;464:1052-1057. [PMID: 20393564 DOI: 10.1038/nature08878] [Cited by in Crossref: 497] [Cited by in F6Publishing: 468] [Article Influence: 41.4] [Reference Citation Analysis]
342 Cao Y, Zhong W. Tumor-derived lymphangiogenic factors and lymphatic metastasis. Biomed Pharmacother. 2007;61:534-539. [PMID: 17904785 DOI: 10.1016/j.biopha.2007.08.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
343 Izrailit J, Reedijk M. Developmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications. Cancer Letters 2012;317:115-26. [DOI: 10.1016/j.canlet.2011.11.028] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
344 Benedito R, Hellström M. Notch as a hub for signaling in angiogenesis. Exp Cell Res. 2013;319:1281-1288. [PMID: 23328307 DOI: 10.1016/j.yexcr.2013.01.010] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]
345 Azam F, Mehta S, Harris AL. Mechanisms of resistance to antiangiogenesis therapy. Eur J Cancer 2010;46:1323-32. [PMID: 20236818 DOI: 10.1016/j.ejca.2010.02.020] [Cited by in Crossref: 116] [Cited by in F6Publishing: 109] [Article Influence: 9.7] [Reference Citation Analysis]
346 Carvalho FL, Simons BW, Eberhart CG, Berman DM. Notch signaling in prostate cancer: a moving target. Prostate 2014;74:933-45. [PMID: 24737393 DOI: 10.1002/pros.22811] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
347 Miles KM, Seshadri M, Ciamporcero E, Adelaiye R, Gillard B, Sotomayor P, Attwood K, Shen L, Conroy D, Kuhnert F. Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts. PLoS One. 2014;9:e112371. [PMID: 25393540 DOI: 10.1371/journal.pone.0112371] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
348 Hofmann JJ, Iruela-Arispe ML. Notch signaling in blood vessels: who is talking to whom about what? Circ Res. 2007;100:1556-1568. [PMID: 17556669 DOI: 10.1161/01.res.0000266408.42939.e4] [Cited by in Crossref: 158] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
349 Silva EA, Mooney DJ. Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials. 2010;31:1235-1241. [PMID: 19906422 DOI: 10.1016/j.biomaterials.2009.10.052] [Cited by in Crossref: 164] [Cited by in F6Publishing: 146] [Article Influence: 12.6] [Reference Citation Analysis]
350 Mamaeva V, Rosenholm JM, Bate-Eya LT, Bergman L, Peuhu E, Duchanoy A, Fortelius LE, Landor S, Toivola DM, Lindén M, Sahlgren C. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. Mol Ther 2011;19:1538-46. [PMID: 21629222 DOI: 10.1038/mt.2011.105] [Cited by in Crossref: 155] [Cited by in F6Publishing: 136] [Article Influence: 14.1] [Reference Citation Analysis]
351 Gaur P, Bose D, Samuel S, Ellis LM. Targeting tumor angiogenesis. Semin Oncol 2009;36:S12-9. [PMID: 19393831 DOI: 10.1053/j.seminoncol.2009.02.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
352 Galan Moya EM, Le Guelte A, Gavard J. PAKing up to the endothelium. Cell Signal 2009;21:1727-37. [PMID: 19720142 DOI: 10.1016/j.cellsig.2009.08.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
353 Sivaraj KK, Dharmalingam B, Mohanakrishnan V, Jeong HW, Kato K, Schröder S, Adams S, Koh GY, Adams RH. YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells. Elife 2020;9:e50770. [PMID: 31958058 DOI: 10.7554/eLife.50770] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
354 Arreola A, Payne LB, Julian MH, de Cubas AA, Daniels AB, Taylor S, Zhao H, Darden J, Bautch VL, Rathmell WK, Chappell JC. Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch. JCI Insight 2018;3:92193. [PMID: 29467323 DOI: 10.1172/jci.insight.92193] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
355 Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. BMC Cancer 2010;10:641. [PMID: 21092311 DOI: 10.1186/1471-2407-10-641] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
356 Wang W, Yu Y, Wang Y, Li X, Bao J, Wu G, Chang H, Shi T, Yue Z. Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma. Oncol Lett 2014;8:2627-33. [PMID: 25364440 DOI: 10.3892/ol.2014.2554] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
357 Canalis E. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders. Metabolism 2018;80:48-56. [PMID: 28941602 DOI: 10.1016/j.metabol.2017.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
358 Sahebjam S, Bedard PL, Castonguay V, Chen Z, Reedijk M, Liu G, Cohen B, Zhang WJ, Clarke B, Zhang T, Kamel-Reid S, Chen H, Ivy SP, Razak AR, Oza AM, Chen EX, Hirte HW, McGarrity A, Wang L, Siu LL, Hotte SJ. A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503). Br J Cancer 2013;109:943-9. [PMID: 23868004 DOI: 10.1038/bjc.2013.380] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
359 Silva MD, Yerby B, Moriguchi J, Gomez A, Toni Jun H, Coxon A, Ungersma SE. Response-Derived Input Function Estimation for Dynamic Contrast-Enhanced MRI Demonstrated by Anti-DLL4 Treatment in a Murine U87 Xenograft Model. Mol Imaging Biol 2017;19:673-82. [PMID: 28265853 DOI: 10.1007/s11307-017-1065-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
360 Garcia A, Kandel JJ. Notch: a key regulator of tumor angiogenesis and metastasis. Histol Histopathol 2012;27:151-6. [PMID: 22207549 DOI: 10.14670/HH-27.151] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
361 Qiu XX, Chen L, Wang CH, Lin ZX, Zhou CF, Liu SY, Wang XF, Chen YP. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma. Medicine (Baltimore) 2014;93:e57. [PMID: 25121357 DOI: 10.1097/MD.0000000000000057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
362 Hernandez SL, Nelson M, Sampedro GR, Bagrodia N, Defnet AM, Lec B, Emolo J, Kirschner R, Wu L, Biermann H, Shen S, Bubeck Wardenburg J, Kandel JJ. Staphylococcus aureus alpha toxin activates Notch in vascular cells. Angiogenesis 2019;22:197-209. [PMID: 30324336 DOI: 10.1007/s10456-018-9650-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
363 Karamysheva AF. Mechanisms of angiogenesis. Biochemistry (Mosc). 2008;73:751-762. [PMID: 18707583 DOI: 10.1134/S0006297908070031] [Cited by in Crossref: 159] [Cited by in F6Publishing: 77] [Article Influence: 11.4] [Reference Citation Analysis]
364 Dikic I, Schmidt MHH. Notch: Implications of endogenous inhibitors for therapy. Bioessays 2010;32:481-7. [PMID: 20486134 DOI: 10.1002/bies.200900140] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
365 Trindade A, Djokovic D, Gigante J, Mendonça L, Duarte A. Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo. BMC Cancer 2017;17:189. [PMID: 28288569 DOI: 10.1186/s12885-017-3171-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
366 Ramasamy SK, Kusumbe AP, Schiller M, Zeuschner D, Bixel MG, Milia C, Gamrekelashvili J, Limbourg A, Medvinsky A, Santoro MM, Limbourg FP, Adams RH. Blood flow controls bone vascular function and osteogenesis. Nat Commun 2016;7:13601. [PMID: 27922003 DOI: 10.1038/ncomms13601] [Cited by in Crossref: 136] [Cited by in F6Publishing: 135] [Article Influence: 22.7] [Reference Citation Analysis]
367 Shi S, Li X, Li Y, Pei C, Yang H, Chen X. Expression and function of Delta-like ligand 4 in a rat model of retinopathy of prematurity. Neural Regen Res 2013;8:723-30. [PMID: 25206719 DOI: 10.3969/j.issn.1673-5374.2013.08.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
368 Mckeage MJ, Kotasek D, Markman B, Hidalgo M, Millward MJ, Jameson MB, Harris DL, Stagg RJ, Kapoun AM, Xu L, Hughes BGM. Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC. Targ Oncol 2018;13:89-98. [DOI: 10.1007/s11523-017-0543-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
369 Fernández-Chacón M, García-González I, Mühleder S, Benedito R. Role of Notch in endothelial biology. Angiogenesis 2021;24:237-50. [PMID: 34050878 DOI: 10.1007/s10456-021-09793-7] [Reference Citation Analysis]
370 Geers C, Colin IM, Gérard AC. Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues. Thyroid 2011;21:1323-30. [PMID: 22066479 DOI: 10.1089/thy.2010.0444] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
371 Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta. 2011;1815:197-213. [PMID: 21193018 DOI: 10.1016/j.bbcan.2010.12.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 116] [Article Influence: 3.9] [Reference Citation Analysis]
372 Pietras A. Cancer stem cells in tumor heterogeneity. Adv Cancer Res. 2011;112:255-281. [PMID: 21925307 DOI: 10.1016/b978-0-12-387688-1.00009-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
373 Kirschmann DA, Seftor EA, Hardy KM, Seftor RE, Hendrix MJ. Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res. 2012;18:2726-2732. [PMID: 22474319 DOI: 10.1158/1078-0432.ccr-11-3237] [Cited by in Crossref: 179] [Cited by in F6Publishing: 113] [Article Influence: 17.9] [Reference Citation Analysis]
374 Ellis LM, Hicklin DJ. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 2008;8:579-91. [DOI: 10.1038/nrc2403] [Cited by in Crossref: 1126] [Cited by in F6Publishing: 1046] [Article Influence: 80.4] [Reference Citation Analysis]
375 Tamagnone L, Zacchigna S, Rehman M. Taming the Notch Transcriptional Regulator for Cancer Therapy. Molecules 2018;23:E431. [PMID: 29462871 DOI: 10.3390/molecules23020431] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
376 Ohnuki H, Inoue H, Takemori N, Nakayama H, Sakaue T, Fukuda S, Miwa D, Nishiwaki E, Hatano M, Tokuhisa T. BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis. Blood. 2012;119:2688-2698. [PMID: 22279058 DOI: 10.1182/blood-2011-03-345306] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
377 Koutras AK, Fountzilas G, Makatsoris T, Peroukides S, Kalofonos HP. Bevacizumab in the treatment of breast cancer. Cancer Treat Rev 2010;36:75-82. [PMID: 19932567 DOI: 10.1016/j.ctrv.2009.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
378 Eichten A, Adler AP, Cooper B, Griffith J, Wei Y, Yancopoulos GD, Lin HC, Thurston G. Rapid decrease in tumor perfusion following VEGF blockade predicts long-term tumor growth inhibition in preclinical tumor models. Angiogenesis 2013;16:429-41. [PMID: 23238831 DOI: 10.1007/s10456-012-9328-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
379 Pulkkinen HH, Kiema M, Lappalainen JP, Toropainen A, Beter M, Tirronen A, Holappa L, Niskanen H, Kaikkonen MU, Ylä-Herttuala S, Laakkonen JP. BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF. Angiogenesis 2021;24:129-44. [PMID: 33021694 DOI: 10.1007/s10456-020-09748-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
380 Saltarella I, Frassanito MA, Lamanuzzi A, Brevi A, Leone P, Desantis V, Di Marzo L, Bellone M, Derudas D, Ribatti D, Chiaramonte R, Palano MT, Neri A, Mariggiò MA, Fumarulo R, Dammacco F, Racanelli V, Vacca A, Ria R. Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target? Neoplasia 2019;21:93-105. [PMID: 30529074 DOI: 10.1016/j.neo.2018.10.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
381 Sundlisaeter E, Edelmann RJ, Hol J, Sponheim J, Küchler AM, Weiss M, Udalova IA, Midwood KS, Kasprzycka M, Haraldsen G. The alarmin IL-33 is a notch target in quiescent endothelial cells. Am J Pathol 2012;181:1099-111. [PMID: 22809957 DOI: 10.1016/j.ajpath.2012.06.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
382 Benton RL, Maddie MA, Gruenthal MJ, Hagg T, Whittemore SR. Neutralizing endogenous VEGF following traumatic spinal cord injury modulates microvascular plasticity but not tissue sparing or functional recovery. Curr Neurovasc Res 2009;6:124-31. [PMID: 19442162 DOI: 10.2174/156720209788185678] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
383 Sethi N, Kang Y. Notch signalling in cancer progression and bone metastasis. Br J Cancer 2011;105:1805-10. [PMID: 22075946 DOI: 10.1038/bjc.2011.497] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
384 Shao H, Huang Q, Liu ZJ. Targeting Notch signaling for cancer therapeutic intervention. Adv Pharmacol. 2012;65:191-234. [PMID: 22959027 DOI: 10.1016/b978-0-12-397927-8.00007-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
385 Irvin DK, Jouanneau E, Duvall G, Zhang XX, Zhai Y, Sarayba D, Seksenyan A, Panwar A, Black KL, Wheeler CJ. T cells enhance stem-like properties and conditional malignancy in gliomas. PLoS One 2010;5:e10974. [PMID: 20539758 DOI: 10.1371/journal.pone.0010974] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
386 Deng G, Ma L, Meng Q, Ju X, Jiang K, Jiang P, Yu Z. Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology. J Cancer Res Clin Oncol 2016;142:531-47. [PMID: 25736982 DOI: 10.1007/s00432-015-1946-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
387 Watson EC, Adams RH. Biology of Bone: The Vasculature of the Skeletal System. Cold Spring Harb Perspect Med 2018;8:a031559. [PMID: 28893838 DOI: 10.1101/cshperspect.a031559] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
388 Cuesta-Mateos C, Alcaraz-Serna A, Somovilla-Crespo B, Muñoz-Calleja C. Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets. Front Immunol 2017;8:1936. [PMID: 29387053 DOI: 10.3389/fimmu.2017.01936] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
389 Liu R, Trindade A, Sun Z, Kumar R, Weaver FA, Krasnoperov V, Naga K, Duarte A, Gill PS. Inhibition of Notch signaling by Dll4-Fc promotes reperfusion of acutely ischemic tissues. Biochemical and Biophysical Research Communications 2012;418:173-9. [DOI: 10.1016/j.bbrc.2012.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
390 Soler A, Serra H, Pearce W, Angulo A, Guillermet-Guibert J, Friedman LS, Viñals F, Gerhardt H, Casanovas O, Graupera M, Vanhaesebroeck B. Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis. J Exp Med 2013;210:1937-45. [PMID: 24043760 DOI: 10.1084/jem.20121571] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
391 Zhang J, Ye J, Ma D, Liu N, Wu H, Yu S, Sun X, Tse W, Ji C. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway. Carcinogenesis 2013;34:667-77. [PMID: 23239744 DOI: 10.1093/carcin/bgs386] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
392 Nie S, Wang Z, Moscoso-Castro M, D'Souza P, Lei C, Xu J, Gu J. Biology drives the discovery of bispecific antibodies as innovative therapeutics. Antib Ther 2020;3:18-62. [PMID: 33928225 DOI: 10.1093/abt/tbaa003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
393 Leach A, Smyth P, Ferguson L, Steven J, Greene MK, Branco CM, McCann AP, Porter A, Barelle CJ, Scott CJ. Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature. Nanoscale 2020;12:14751-63. [PMID: 32626858 DOI: 10.1039/d0nr02962a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
394 Clarke JM, Hurwitz HI. Understanding and targeting resistance to anti-angiogenic therapies. J Gastrointest Oncol. 2013;4:253-263. [PMID: 23997938 DOI: 10.3978/j.issn.2078-6891.2013.036] [Cited by in F6Publishing: 39] [Reference Citation Analysis]
395 Fukusumi T, Califano JA. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma. J Dent Res 2018;97:645-53. [PMID: 29489439 DOI: 10.1177/0022034518760297] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
396 Sierra JR, Cepero V, Giordano S. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy. Mol Cancer 2010;9:75. [PMID: 20385023 DOI: 10.1186/1476-4598-9-75] [Cited by in Crossref: 142] [Cited by in F6Publishing: 134] [Article Influence: 11.8] [Reference Citation Analysis]
397 Baluk P, McDonald DM. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 2008;1131:1-12. [PMID: 18519955 DOI: 10.1196/annals.1413.001] [Cited by in Crossref: 143] [Cited by in F6Publishing: 139] [Article Influence: 10.2] [Reference Citation Analysis]
398 Kangsamaksin T, Tattersall IW, Kitajewski J. Notch functions in developmental and tumour angiogenesis by diverse mechanisms. Biochem Soc Trans 2014;42:1563-8. [PMID: 25399571 DOI: 10.1042/BST20140233] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
399 Ren K, Yuan J, Yang M, Gao X, Ding X, Zhou J, Hu X, Cao J, Deng X, Xiang S, Zhang J. KCTD10 is involved in the cardiovascular system and Notch signaling during early embryonic development. PLoS One 2014;9:e112275. [PMID: 25401743 DOI: 10.1371/journal.pone.0112275] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
400 Cao R, Jensen LD, Söll I, Hauptmann G, Cao Y. Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy. PLoS One 2008;3:e2748. [PMID: 18648503 DOI: 10.1371/journal.pone.0002748] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 7.0] [Reference Citation Analysis]
401 Jayson GC, Kerbel R, Ellis LM, Harris AL. Antiangiogenic therapy in oncology: current status and future directions. The Lancet 2016;388:518-29. [DOI: 10.1016/s0140-6736(15)01088-0] [Cited by in Crossref: 412] [Cited by in F6Publishing: 235] [Article Influence: 68.7] [Reference Citation Analysis]
402 Bridges EM, Harris AL. The angiogenic process as a therapeutic target in cancer. Biochemical Pharmacology 2011;81:1183-91. [DOI: 10.1016/j.bcp.2011.02.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
403 Pannella M, Caliceti C, Fortini F, Aquila G, Vieceli Dalla Sega F, Pannuti A, Fortini C, Morelli MB, Fucili A, Francolini G, Voltan R, Secchiero P, Dinelli G, Leoncini E, Ferracin M, Hrelia S, Miele L, Rizzo P. Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells. J Cell Physiol 2016;231:2700-10. [PMID: 26987674 DOI: 10.1002/jcp.25373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
404 Gamboa NT, Taussky P, Park MS, Couldwell WT, Mahan MA, Kalani MYS. Neurovascular patterning cues and implications for central and peripheral neurological disease. Surg Neurol Int 2017;8:208. [PMID: 28966815 DOI: 10.4103/sni.sni_475_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
405 Iwamoto H, Zhang Y, Seki T, Yang Y, Nakamura M, Wang J, Yang X, Torimura T, Cao Y. PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors. Sci Adv 2015;1:e1400244. [PMID: 26601163 DOI: 10.1126/sciadv.1400244] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
406 Speiser JJ, Erşahin C, Osipo C. The functional role of Notch signaling in triple-negative breast cancer. Vitam Horm 2013;93:277-306. [PMID: 23810012 DOI: 10.1016/B978-0-12-416673-8.00013-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
407 Jabs M, Rose AJ, Lehmann LH, Taylor J, Moll I, Sijmonsma TP, Herberich SE, Sauer SW, Poschet G, Federico G, Mogler C, Weis EM, Augustin HG, Yan M, Gretz N, Schmid RM, Adams RH, Gröne HJ, Hell R, Okun JG, Backs J, Nawroth PP, Herzig S, Fischer A. Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult Heart. Circulation 2018;137:2592-608. [PMID: 29353241 DOI: 10.1161/CIRCULATIONAHA.117.029733] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
408 Muñoz R, Arias Y, Ferreras JM, Rojo MA, Gayoso MJ, Nocito M, Benitez J, Jiménez P, Bernabéu C, Girbés T. Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b. Cancer Letters 2007;256:73-80. [DOI: 10.1016/j.canlet.2007.05.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
409 Yahyanejad S, King H, Iglesias VS, Granton PV, Barbeau LM, van Hoof SJ, Groot AJ, Habets R, Prickaerts J, Chalmers AJ, Eekers DB, Theys J, Short SC, Verhaegen F, Vooijs M. NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma. Oncotarget 2016;7:41251-64. [PMID: 27183910 DOI: 10.18632/oncotarget.9275] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
410 Majumder S, Crabtree JS, Golde TE, Minter LM, Osborne BA, Miele L. Targeting Notch in oncology: the path forward. Nat Rev Drug Discov 2021;20:125-44. [PMID: 33293690 DOI: 10.1038/s41573-020-00091-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
411 Stewart KS, Zhou Z, Zweidler-McKay P, Kleinerman ES. Delta-like ligand 4-Notch signaling regulates bone marrow-derived pericyte/vascular smooth muscle cell formation. Blood 2011;117:719-26. [PMID: 20944072 DOI: 10.1182/blood-2010-05-284869] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
412 Chen J, Cui X, Zacharek A, Ding GL, Shehadah A, Jiang Q, Lu M, Chopp M. Niaspan treatment increases tumor necrosis factor-alpha-converting enzyme and promotes arteriogenesis after stroke. J Cereb Blood Flow Metab 2009;29:911-20. [PMID: 19223914 DOI: 10.1038/jcbfm.2009.11] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
413 Jin Y, Jakobsson L. The dynamics of developmental and tumor angiogenesis-a comparison. Cancers (Basel) 2012;4:400-19. [PMID: 24213317 DOI: 10.3390/cancers4020400] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
414 Pindiprolu SKSS, Krishnamurthy PT, Chintamaneni PK, Karri VVSR. Nanocarrier based approaches for targeting breast cancer stem cells. Artif Cells Nanomed Biotechnol 2018;46:885-98. [PMID: 28826237 DOI: 10.1080/21691401.2017.1366337] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
415 Chigurupati S, Arumugam TV, Son TG, Lathia JD, Jameel S, Mughal MR, Tang SC, Jo DG, Camandola S, Giunta M, Rakova I, McDonnell N, Miele L, Mattson MP, Poosala S. Involvement of notch signaling in wound healing. PLoS One 2007;2:e1167. [PMID: 18000539 DOI: 10.1371/journal.pone.0001167] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 6.0] [Reference Citation Analysis]
416 Shimizu H, Okamoto R, Ito G, Fujii S, Nakata T, Suzuki K, Murano T, Mizutani T, Tsuchiya K, Nakamura T, Hozumi K, Watanabe M. Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine. PeerJ 2014;2:e370. [PMID: 24860699 DOI: 10.7717/peerj.370] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
417 Bhattarai P, Hameed S, Dai Z. Recent advances in anti-angiogenic nanomedicines for cancer therapy. Nanoscale 2018;10:5393-423. [DOI: 10.1039/c7nr09612g] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
418 Catalano V, Eleuteri C, Campoccia G, Giacobini G, Zane M, Stassi G, Parmiani G, Maccalli C. Resistance of Cancer Stem Cells to Cell-Mediated Immune Responses. In: Bonavida B, Chouaib S, editors. Resistance of Cancer Cells to CTL-Mediated Immunotherapy. Cham: Springer International Publishing; 2015. pp. 3-29. [DOI: 10.1007/978-3-319-17807-3_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
419 Li S, Xu G, Gao F, Bi J, Huo R. Expression and association of VEGF-Notch pathways in infantile hemangiomas. Exp Ther Med 2017;14:3737-43. [PMID: 29042972 DOI: 10.3892/etm.2017.4943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
420 Cheng F, Pekkonen P, Ojala PM. Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses. Future Microbiol 2012;7:1191-205. [PMID: 23030424 DOI: 10.2217/fmb.12.95] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
421 Chand R, Chandra H, Chandra S, Verma SK. Role of Microvessel Density and Vascular Endothelial Growth Factor in Angiogenesis of Hematological Malignancies. Bone Marrow Research 2016;2016:1-4. [DOI: 10.1155/2016/5043483] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
422 Oon CE, Harris AL. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis. Biochem Soc Trans. 2011;39:1612-1618. [PMID: 22103496 DOI: 10.1042/bst20110721] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
423 Porcheri C, Mitsiadis TA. Notch in Head and Neck Cancer. Adv Exp Med Biol 2021;1287:81-103. [PMID: 33034028 DOI: 10.1007/978-3-030-55031-8_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
424 Martinez JC, Müller MM, Turley H, Steers G, Choteau L, Li JL, Sainson R, Harris AL, Pezzella F, Gatter KC. Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues. Histopathology. 2009;54:598-606. [PMID: 19413639 DOI: 10.1111/j.1365-2559.2009.03279.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
425 Wang H, Huang X, Zhang J, Shao N, Chen LO, Ma D, Ji C. The expression of VEGF and Dll4/Notch pathway molecules in ovarian cancer. Clin Chim Acta 2014;436:243-8. [PMID: 24949865 DOI: 10.1016/j.cca.2014.06.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
426 Crawford Y, Ferrara N. Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies. Trends Pharmacol Sci 2009;30:624-30. [PMID: 19836845 DOI: 10.1016/j.tips.2009.09.004] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 8.9] [Reference Citation Analysis]
427 Wang S, Zhu G, Jiang D, Rhen J, Li X, Liu H, Lyu Y, Tsai P, Rose Y, Nguyen T, White RJ, Pryhuber GS, Mariani TJ, Li C, Mohan A, Xu Y, Pang J. Reduced Notch1 Cleavage Promotes the Development of Pulmonary Hypertension. Hypertension 2021;:HYPERTENSIONAHA12016065. [PMID: 34739767 DOI: 10.1161/HYPERTENSIONAHA.120.16065] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Cha YR, Weinstein BM. Visualization and experimental analysis of blood vessel formation using transgenic zebrafish. Birth Defects Res C Embryo Today 2007;81:286-96. [PMID: 18228261 DOI: 10.1002/bdrc.20103] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
429 Siebel C, Lendahl U. Notch Signaling in Development, Tissue Homeostasis, and Disease. Physiol Rev. 2017;97:1235-1294. [PMID: 28794168 DOI: 10.1152/physrev.00005.2017] [Cited by in Crossref: 291] [Cited by in F6Publishing: 280] [Article Influence: 58.2] [Reference Citation Analysis]
430 Rojas JD, Lin F, Chiang YC, Chytil A, Chong DC, Bautch VL, Rathmell WK, Dayton PA. Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 2018;8:141-55. [PMID: 29290798 DOI: 10.7150/thno.19658] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
431 Hedlund EM, Hosaka K, Zhong Z, Cao R, Cao Y. Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature. Proc Natl Acad Sci U S A 2009;106:17505-10. [PMID: 19805167 DOI: 10.1073/pnas.0908026106] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
432 Chung J, Riella LV, Maillard I. Targeting the Notch Pathway to Prevent Rejection. Am J Transplant 2016;16:3079-85. [PMID: 27037759 DOI: 10.1111/ajt.13816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
433 Ishigami S, Arigami T, Uenosono Y, Okumura H, Kurahara H, Uchikado Y, Setoyama T, Kita Y, Kijima Y, Nishizono Y. Clinical implications of DLL4 expression in gastric cancer. J Exp Clin Cancer Res. 2013;32:46. [PMID: 23898884 DOI: 10.1186/1756-9966-32-46] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
434 Zardavas D, Baselga J, Piccart M. Emerging targeted agents in metastatic breast cancer. Nat Rev Clin Oncol 2013;10:191-210. [PMID: 23459626 DOI: 10.1038/nrclinonc.2013.29] [Cited by in Crossref: 129] [Cited by in F6Publishing: 118] [Article Influence: 14.3] [Reference Citation Analysis]
435 Sun H, Zhu MS, Wu WR, Shi XD, Xu LB. Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out. World J Hepatol 2014; 6(12): 830-835 [PMID: 25544869 DOI: 10.4254/wjh.v6.i12.830] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
436 Yang MH, Chang KJ, Zheng JC, Huang H, Sun GY, Zhao XW, Li B, Xiu QY. Anti-angiogenic effect of arsenic trioxide in lung cancer via inhibition of endothelial cell migration, proliferation and tube formation. Oncol Lett 2017;14:3103-9. [PMID: 28928847 DOI: 10.3892/ol.2017.6518] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
437 Zhao Y, Alakhova DY, Kabanov AV. Can nanomedicines kill cancer stem cells? Adv Drug Deliv Rev. 2013;65:1763-1783. [PMID: 24120657 DOI: 10.1016/j.addr.2013.09.016] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 9.2] [Reference Citation Analysis]
438 Ubezio B, Blanco RA, Geudens I, Stanchi F, Mathivet T, Jones ML, Ragab A, Bentley K, Gerhardt H. Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion. Elife 2016;5:e12167. [PMID: 27074663 DOI: 10.7554/eLife.12167] [Cited by in Crossref: 71] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
439 Gerhardt H. VEGF and Endothelial Guidance in Angiogenic Sprouting. VEGF in Development. New York: Springer; 2008. pp. 68-78. [DOI: 10.1007/978-0-387-78632-2_6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
440 Yin Z, Noren D, Wang CJ, Hang R, Levchenko A. Analysis of pairwise cell interactions using an integrated dielectrophoretic-microfluidic system. Mol Syst Biol 2008;4:232. [PMID: 19096359 DOI: 10.1038/msb.2008.69] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
441 Abbas OL. Inhibition of the Notch Pathway Promotes Flap Survival by Inducing Functional Angiogenesis: Reply. Ann Plast Surg 2015;75:579-80. [PMID: 26461102 DOI: 10.1097/SAP.0000000000000500] [Reference Citation Analysis]
442 Hayakawa S, Koide R, Hinou H, Nishimura S. Synthetic Human NOTCH1 EGF Modules Unraveled Molecular Mechanisms for the Structural and Functional Roles of Calcium Ions and O -Glycans in the Ligand-Binding Region. Biochemistry 2016;55:776-87. [DOI: 10.1021/acs.biochem.5b01284] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
443 Chen HJ, Edwards R, Tucci S, Bu P, Milsom J, Lee S, Edelmann W, Gümüs ZH, Shen X, Lipkin S. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. J Clin Invest 2012;122:3184-96. [PMID: 22863617 DOI: 10.1172/JCI62110] [Cited by in Crossref: 55] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
444 Abbas OL, Özatik O, Terzi YK, Özatik FY, Nar R, Turna G. The Notch Signaling System Is Involved in the Regulation of Reparative Angiogenesis in the Zone of Stasis. J Burn Care Res 2017;38:e923-33. [PMID: 28319529 DOI: 10.1097/BCR.0000000000000522] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
445 Fakhrejahani E, Toi M. Tumor angiogenesis: pericytes and maturation are not to be ignored. J Oncol 2012;2012:261750. [PMID: 22007214 DOI: 10.1155/2012/261750] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
446 Kwon SM, Alev C, Lee SH, Asahara T. The molecular basis of Notch signaling: a brief overview. Adv Exp Med Biol 2012;727:1-14. [PMID: 22399335 DOI: 10.1007/978-1-4614-0899-4_1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
447 Kashikar ND, Zhang W, Massion PP, Gonzalez AL, Datta PK. Role of STRAP in regulating GSK3β function and Notch3 stabilization. Cell Cycle 2011;10:1639-54. [PMID: 21502811 DOI: 10.4161/cc.10.10.15630] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
448 Hale AT, Tian H, Anih E, Recio FO 3rd, Shatat MA, Johnson T, Liao X, Ramirez-Bergeron DL, Proweller A, Ishikawa M, Hamik A. Endothelial Kruppel-like factor 4 regulates angiogenesis and the Notch signaling pathway. J Biol Chem 2014;289:12016-28. [PMID: 24599951 DOI: 10.1074/jbc.M113.530956] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
449 Adams RH, Eichmann A. Axon guidance molecules in vascular patterning. Cold Spring Harb Perspect Biol 2010;2:a001875. [PMID: 20452960 DOI: 10.1101/cshperspect.a001875] [Cited by in Crossref: 257] [Cited by in F6Publishing: 242] [Article Influence: 21.4] [Reference Citation Analysis]
450 Wälchli T, Bisschop J, Miettinen A, Ulmann-Schuler A, Hintermüller C, Meyer EP, Krucker T, Wälchli R, Monnier PP, Carmeliet P, Vogel J, Stampanoni M. Hierarchical imaging and computational analysis of three-dimensional vascular network architecture in the entire postnatal and adult mouse brain. Nat Protoc 2021;16:4564-610. [PMID: 34480130 DOI: 10.1038/s41596-021-00587-1] [Reference Citation Analysis]
451 Bagheri V, Memar B, Behzadi R, Aliakbarian M, Jangjoo A, Bahar MM, Talebi S, Gholamin M, Abbaszadegan MR. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer. J Cell Physiol 2018;233:7036-46. [PMID: 29744869 DOI: 10.1002/jcp.26627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
452 Abbas OL, Borman H, Terzi YK, Terzi A, Bayraktar N, Yazıcı AC. The Notch pathway is a critical regulator of angiogenesis in a skin model of ischemia. Vasc Med 2015;20:205-11. [PMID: 25834117 DOI: 10.1177/1358863X15570723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
453 Rapisarda A, Melillo G. Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies. Drug Resist Updat. 2009;12:74-80. [PMID: 19394890 DOI: 10.1016/j.drup.2009.03.002] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 7.8] [Reference Citation Analysis]
454 Klose R, Adam MG, Weis EM, Moll I, Wüstehube-Lausch J, Tetzlaff F, Oka C, Ehrmann M, Fischer A. Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis. Oncogene 2018;37:4260-72. [PMID: 29713059 DOI: 10.1038/s41388-018-0258-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
455 Leite de Oliveira R, Hamm A, Mazzone M. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies. Mol Aspects Med 2011;32:71-87. [PMID: 21540050 DOI: 10.1016/j.mam.2011.04.001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
456 Cigliano A, Wang J, Chen X, Calvisi DF. Role of the Notch signaling in cholangiocarcinoma. Expert Opin Ther Targets. 2017;21:471-483. [PMID: 28326864 DOI: 10.1080/14728222.2017.1310842] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
457 Trindade A, Duarte A. Notch Signaling Function in the Angiocrine Regulation of Tumor Development. Cells 2020;9:E2467. [PMID: 33198378 DOI: 10.3390/cells9112467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
458 Gianni-Barrera R, Trani M, Reginato S, Banfi A. To sprout or to split? VEGF, Notch and vascular morphogenesis. Biochem Soc Trans 2011;39:1644-8. [PMID: 22103501 DOI: 10.1042/BST20110650] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
459 Camelo S, Raoul W, Lavalette S, Calippe B, Cristofaro B, Levy O, Houssier M, Sulpice E, Jonet L, Klein C. Delta-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages. Angiogenesis. 2012;15:609-622. [PMID: 22869002 DOI: 10.1007/s10456-012-9290-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
460 Gurney A, Hoey T. Anti-DLL4, a cancer therapeutic with multiple mechanisms of action. Vasc Cell. 2011;3:18. [PMID: 21831306 DOI: 10.1186/2045-824x-3-18] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
461 Yamakawa D, Jia W, Kidoya H, Hosojima S, Torigata M, Zhang L, Takakura N. Visualization of Proliferative Vascular Endothelial Cells in Tumors in Vivo by Imaging Their Partner of Sld5-1 Promoter Activity. The American Journal of Pathology 2018;188:1300-14. [DOI: 10.1016/j.ajpath.2018.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
462 Nandikolla AG, Rajdev L. Targeting angiogenesis in gastrointestinal tumors: current challenges. Transl Gastroenterol Hepatol 2016;1:67. [PMID: 28138633 DOI: 10.21037/tgh.2016.08.04] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
463 Chi AS, Sorensen AG, Jain RK, Batchelor TT. Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 2009;14:621-36. [PMID: 19487335 DOI: 10.1634/theoncologist.2008-0272] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 5.8] [Reference Citation Analysis]
464 Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137:216-233. [PMID: 19379690 DOI: 10.1016/j.cell.2009.03.045] [Cited by in Crossref: 2158] [Cited by in F6Publishing: 2076] [Article Influence: 166.0] [Reference Citation Analysis]
465 Zheng H, Bae Y, Kasimir-Bauer S, Tang R, Chen J, Ren G, Yuan M, Esposito M, Li W, Wei Y, Shen M, Zhang L, Tupitsyn N, Pantel K, King C, Sun J, Moriguchi J, Jun HT, Coxon A, Lee B, Kang Y. Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy. Cancer Cell 2017;32:731-747.e6. [PMID: 29232552 DOI: 10.1016/j.ccell.2017.11.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 15.4] [Reference Citation Analysis]
466 Faes S, Uldry E, Planche A, Santoro T, Pythoud C, Demartines N, Dormond O. Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies. Oncotarget 2016;7:86026-38. [PMID: 27852069 DOI: 10.18632/oncotarget.13323] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
467 Choi WH, Jo HR, Jeon EJ, Youm SY, Jeon JS, Son YG, You WK, Koh WS, Lee SH, Kim SK. Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys. J Pharm Biomed Anal 2016;131:309-15. [PMID: 27619177 DOI: 10.1016/j.jpba.2016.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
468 Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol 2012;11:369-80. [PMID: 22441198 DOI: 10.1016/S1474-4422(12)70039-X] [Cited by in Crossref: 213] [Cited by in F6Publishing: 128] [Article Influence: 21.3] [Reference Citation Analysis]
469 Abetov D, Mustapova Z, Saliev T, Bulanin D, Batyrbekov K, Gilman CP. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways. Stem Cell Rev Rep 2015;11:909-18. [PMID: 26210995 DOI: 10.1007/s12015-015-9612-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
470 Zhu SS, Li WG. Advances in research of signaling pathways in cholangiocarcinoma. Shijie Huaren Xiaohua Zazhi 2012; 20(30): 2913-2919 [DOI: 10.11569/wcjd.v20.i30.2913] [Reference Citation Analysis]
471 Wang W, Yu S, Zimmerman G, Wang Y, Myers J, Yu VW, Huang D, Huang X, Shim J, Huang Y, Xin W, Qiao P, Yan M, Xin W, Scadden DT, Stanley P, Lowe JB, Huang AY, Siebel CW, Zhou L. Notch Receptor-Ligand Engagement Maintains Hematopoietic Stem Cell Quiescence and Niche Retention. Stem Cells 2015;33:2280-93. [PMID: 25851125 DOI: 10.1002/stem.2031] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
472 Shukrun R, Pode Shakked N, Dekel B. Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example. Pediatr Nephrol 2014;29:815-23; quiz 821. [PMID: 23760992 DOI: 10.1007/s00467-013-2501-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
473 Kim D, Lee J, Kang J, Kim SH, Yoo TK, Oh S, Lee A. Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer. J Breast Cancer 2019;22:562-78. [PMID: 31897330 DOI: 10.4048/jbc.2019.22.e56] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
474 Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene. 2008;27:5124-5131. [PMID: 18758481 DOI: 10.1038/onc.2008.226] [Cited by in Crossref: 272] [Cited by in F6Publishing: 266] [Article Influence: 19.4] [Reference Citation Analysis]
475 Yuen WW, Du NR, Chan CH, Silva EA, Mooney DJ. Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones. Proc Natl Acad Sci U S A 2010;107:17933-8. [PMID: 20921366 DOI: 10.1073/pnas.1001192107] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
476 Kume T. Novel insights into the differential functions of Notch ligands in vascular formation. J Angiogenes Res. 2009;1:8. [PMID: 20016694 DOI: 10.1186/2040-2384-1-8] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 5.6] [Reference Citation Analysis]
477 Sainson RCA, Harris AL. Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies. Angiogenesis 2008;11:41-51. [DOI: 10.1007/s10456-008-9098-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]
478 Wang Q, Shi Y, Butler HJ, Xue J, Wang G, Duan P, Zheng H. Role of delta-like ligand-4 in chemoresistance against docetaxel in MCF-7 cells. Hum Exp Toxicol 2017;36:328-38. [PMID: 27334972 DOI: 10.1177/0960327116650006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
479 Alvarez-Vergara MI, Rosales-Nieves AE, March-Diaz R, Rodriguez-Perinan G, Lara-Ureña N, Ortega-de San Luis C, Sanchez-Garcia MA, Martin-Bornez M, Gómez-Gálvez P, Vicente-Munuera P, Fernandez-Gomez B, Marchena MA, Bullones-Bolanos AS, Davila JC, Gonzalez-Martinez R, Trillo-Contreras JL, Sanchez-Hidalgo AC, Del Toro R, Scholl FG, Herrera E, Trepel M, Körbelin J, Escudero LM, Villadiego J, Echevarria M, de Castro F, Gutierrez A, Rabano A, Vitorica J, Pascual A. Non-productive angiogenesis disassembles Aß plaque-associated blood vessels. Nat Commun 2021;12:3098. [PMID: 34035282 DOI: 10.1038/s41467-021-23337-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
480 Sorensen EW, Gerber SA, Frelinger JG, Lord EM. IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms. J Immunol 2010;184:1858-66. [PMID: 20061409 DOI: 10.4049/jimmunol.0903210] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
481 Real PJ, Ferrando AA. NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. Leukemia. 2009;23:1374-1377. [PMID: 19357700 DOI: 10.1038/nature04703] [Cited by in Crossref: 958] [Cited by in F6Publishing: 895] [Article Influence: 73.7] [Reference Citation Analysis]
482 Deonarain MP, Kousparou CA, Epenetos AA. Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs. 2009;1:12-25. [PMID: 20046569 DOI: 10.4161/mabs.1.1.7347] [Cited by in Crossref: 107] [Cited by in F6Publishing: 97] [Article Influence: 8.9] [Reference Citation Analysis]
483 Morrow D, Hatch E, Hamm K, Cahill PA, Redmond EM. Flk-1/KDR mediates ethanol-stimulated endothelial cell Notch signaling and angiogenic activity. J Vasc Res 2014;51:315-24. [PMID: 25322777 DOI: 10.1159/000367807] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
484 Remédio L, Carvalho T, Caiado F, Bastos-Carvalho A, Martins D, Duarte A, Yagita H, Dias S. Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment. PLoS One 2012;7:e52450. [PMID: 23285048 DOI: 10.1371/journal.pone.0052450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
485 Espinoza I, Miele L. Notch inhibitors for cancer treatment. Pharmacol Ther 2013;139:95-110. [PMID: 23458608 DOI: 10.1016/j.pharmthera.2013.02.003] [Cited by in Crossref: 178] [Cited by in F6Publishing: 167] [Article Influence: 19.8] [Reference Citation Analysis]
486 Gao Y, Yin Y, Xing X, Zhao Z, Lu Y, Sun Y, Zhuang Z, Wang M, Ji W, He Y. Arsenic-induced anti-angiogenesis via miR-425-5p-regulated CCM3. Toxicology Letters 2016;254:22-31. [DOI: 10.1016/j.toxlet.2016.04.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
487 del Toro R, Prahst C, Mathivet T, Siegfried G, Kaminker JS, Larrivee B, Breant C, Duarte A, Takakura N, Fukamizu A, Penninger J, Eichmann A. Identification and functional analysis of endothelial tip cell-enriched genes. Blood 2010;116:4025-33. [PMID: 20705756 DOI: 10.1182/blood-2010-02-270819] [Cited by in Crossref: 266] [Cited by in F6Publishing: 248] [Article Influence: 22.2] [Reference Citation Analysis]
488 Gharaibeh L, Elmadany N, Alwosaibai K, Alshaer W. Notch1 in Cancer Therapy: Possible Clinical Implications and Challenges. Mol Pharmacol 2020;98:559-76. [PMID: 32913140 DOI: 10.1124/molpharm.120.000006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
489 Luo M, Clouthier SG, Deol Y, Liu S, Nagrath S, Azizi E, Wicha MS. Breast cancer stem cells: current advances and clinical implications. Methods Mol Biol. 2015;1293:1-49. [PMID: 26040679 DOI: 10.1007/978-1-4939-2519-3_1] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
490 Chung J, Ebens CL, Perkey E, Radojcic V, Koch U, Scarpellino L, Tong A, Allen F, Wood S, Feng J, Friedman A, Granadier D, Tran IT, Chai Q, Onder L, Yan M, Reddy P, Blazar BR, Huang AY, Brennan TV, Bishop DK, Ludewig B, Siebel CW, Radtke F, Luther SA, Maillard I. Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. J Clin Invest 2017;127:1574-88. [PMID: 28319044 DOI: 10.1172/JCI89535] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 8.4] [Reference Citation Analysis]
491 Xiu MX, Liu YM, Kuang BH. The Role of DLLs in Cancer: A Novel Therapeutic Target. Onco Targets Ther 2020;13:3881-901. [PMID: 32440154 DOI: 10.2147/OTT.S244860] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
492 Pasula S, Cai X, Dong Y, Messa M, McManus J, Chang B, Liu X, Zhu H, Mansat RS, Yoon SJ, Hahn S, Keeling J, Saunders D, Ko G, Knight J, Newton G, Luscinskas F, Sun X, Towner R, Lupu F, Xia L, Cremona O, De Camilli P, Min W, Chen H. Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. J Clin Invest 2012;122:4424-38. [PMID: 23187125 DOI: 10.1172/JCI64537] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 7.7] [Reference Citation Analysis]
493 Sirin Y, Susztak K. Notch in the kidney: development and disease. J Pathol 2012;226:394-403. [PMID: 21952830 DOI: 10.1002/path.2967] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 7.1] [Reference Citation Analysis]
494 Kamath AV, Yip V, Gupta P, Boswell CA, Bumbaca D, Haughney P, Castro J, Tsai SP, Pacheco G, Ross S, Yan M, Damico-Beyer LA, Khawli L, Shen BQ. Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice. MAbs 2014;6:1631-7. [PMID: 25484068 DOI: 10.4161/mabs.36107] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
495 Grépin R, Pagès G. Molecular mechanisms of resistance to tumour anti-angiogenic strategies. J Oncol 2010;2010:835680. [PMID: 20224655 DOI: 10.1155/2010/835680] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
496 Chappell JC, Mouillesseaux KP, Bautch VL. Flt-1 (vascular endothelial growth factor receptor-1) is essential for the vascular endothelial growth factor-Notch feedback loop during angiogenesis. Arterioscler Thromb Vasc Biol 2013;33:1952-9. [PMID: 23744993 DOI: 10.1161/ATVBAHA.113.301805] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
497 Deville J, Salas S, Figarella-branger D, Ouafik L, Daniel L. Adrenomedullin as a therapeutic target in angiogenesis. Expert Opinion on Therapeutic Targets 2010;14:1059-72. [DOI: 10.1517/14728222.2010.522328] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
498 Narayanappa R, Rout P, Aithal MG, Chand AK. Aberrant expression of Notch1, HES1, and DTX1 genes in glioblastoma formalin-fixed paraffin-embedded tissues. Tumour Biol 2016;37:6935-42. [PMID: 26662803 DOI: 10.1007/s13277-015-4592-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
499 Shibuya M. Tyrosine Kinase Receptor Flt/VEGFR Family: Its Characterization Related to Angiogenesis and Cancer. Genes Cancer 2010;1:1119-23. [PMID: 21779435 DOI: 10.1177/1947601910392987] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
500 Horita N, Keeley TM, Hibdon ES, Delgado E, Lafkas D, Siebel CW, Samuelson LC. Delta-like 1-Expressing Cells at the Gland Base Promote Proliferation of Gastric Antral Stem Cells in Mouse. Cell Mol Gastroenterol Hepatol 2021;13:275-87. [PMID: 34438113 DOI: 10.1016/j.jcmgh.2021.08.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
501 Guichet P, Guelfi S, Teigell M, Hoppe L, Bakalara N, Bauchet L, Duffau H, Lamszus K, Rothhut B, Hugnot J. Notch1 Stimulation Induces a Vascularization Switch With Pericyte-Like Cell Differentiation of Glioblastoma Stem Cells: Notch1 Vascularization of Glioma Stem Cells. Stem Cells 2015;33:21-34. [DOI: 10.1002/stem.1767] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 9.3] [Reference Citation Analysis]
502 Xu Z, Wang Z, Jia X, Wang L, Chen Z, Wang S, Wang M, Zhang J, Wu M. MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth. Cancer Lett 2016;372:118-27. [PMID: 26739060 DOI: 10.1016/j.canlet.2015.12.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
503 Aster JC, Pear WS, Blacklow SC. The Varied Roles of Notch in Cancer. Annu Rev Pathol. 2017;12:245-275. [PMID: 27959635 DOI: 10.1146/annurev-pathol-052016-100127] [Cited by in Crossref: 238] [Cited by in F6Publishing: 228] [Article Influence: 39.7] [Reference Citation Analysis]
504 Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
505 Reedijk M. Notch Signaling and Breast Cancer. In: Reichrath J, Reichrath S, editors. Notch Signaling in Embryology and Cancer. New York: Springer US; 2012. pp. 241-57. [DOI: 10.1007/978-1-4614-0899-4_18] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
506 Jubb AM, Browning L, Campo L, Turley H, Steers G, Thurston G, Harris AL, Ansorge O. Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma. Histopathology 2012;60:740-7. [PMID: 22296176 DOI: 10.1111/j.1365-2559.2011.04138.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
507 Axnick J, Lammert E. Vascular lumen formation: . Current Opinion in Hematology 2012;19:192-8. [DOI: 10.1097/moh.0b013e3283523ebc] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
508 Liu Q, Wang J, Yang H, Gao H, Li C, Lan X, Zhang Y. Attenuation of EGFL7 Expression Inhibits Growth Hormone–Producing Pituitary Adenomas Growth and Invasion. Human Gene Therapy 2018;29:1396-406. [DOI: 10.1089/hum.2017.200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
509 Kassner N, Krueger M, Yagita H, Dzionek A, Hutloff A, Kroczek R, Scheffold A, Rutz S. Cutting Edge: Plasmacytoid Dendritic Cells Induce IL-10 Production in T Cells via the Delta-Like-4/Notch Axis. J I 2010;184:550-4. [DOI: 10.4049/jimmunol.0903152] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
510 Kokai E, Voss F, Fleischer F, Kempe S, Marinkovic D, Wolburg H, Leithäuser F, Schmidt V, Deutsch U, Wirth T. Myc Regulates Embryonic Vascular Permeability and Remodeling. Circulation Research 2009;104:1151-9. [DOI: 10.1161/circresaha.108.191460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
511 Jensen LD, Cao Y. Clock controls angiogenesis. Cell Cycle 2013;12:405-8. [PMID: 23324349 DOI: 10.4161/cc.23596] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
512 Roti G, Stegmaier K. New Approaches to Target T-ALL. Front Oncol 2014;4:170. [PMID: 25072021 DOI: 10.3389/fonc.2014.00170] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
513 Jones D, Li Y, He Y, Xu Z, Chen H, Min W. Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis. Arterioscler Thromb Vasc Biol 2012;32:633-42. [PMID: 22223733 DOI: 10.1161/ATVBAHA.111.243576] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
514 Choi HJ, Armaiz Pena GN, Pradeep S, Cho MS, Coleman RL, Sood AK. Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. Cancer Metastasis Rev 2015;34:19-40. [PMID: 25544368 DOI: 10.1007/s10555-014-9538-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 8.5] [Reference Citation Analysis]
515 Mazzone M, Bergers G. Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis. Annu Rev Physiol 2019;81:535-60. [PMID: 30742781 DOI: 10.1146/annurev-physiol-020518-114721] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
516 Morrow D, Cullen JP, Cahill PA, Redmond EM. Ethanol stimulates endothelial cell angiogenic activity via a Notch- and angiopoietin-1-dependent pathway. Cardiovasc Res 2008;79:313-21. [PMID: 18448572 DOI: 10.1093/cvr/cvn108] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
517 Cheng F, Pekkonen P, Laurinavicius S, Sugiyama N, Henderson S, Günther T, Rantanen V, Kaivanto E, Aavikko M, Sarek G, Hautaniemi S, Biberfeld P, Aaltonen L, Grundhoff A, Boshoff C, Alitalo K, Lehti K, Ojala PM. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. Cell Host Microbe 2011;10:577-90. [PMID: 22177562 DOI: 10.1016/j.chom.2011.10.011] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 8.8] [Reference Citation Analysis]
518 Napp LC, Augustynik M, Paesler F, Krishnasamy K, Woiterski J, Limbourg A, Bauersachs J, Drexler H, Le Noble F, Limbourg FP. Extrinsic Notch ligand Delta-like 1 regulates tip cell selection and vascular branching morphogenesis. Circ Res 2012;110:530-5. [PMID: 22282195 DOI: 10.1161/CIRCRESAHA.111.263319] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
519 Duda DG, Batchelor TT, Willett CG, Jain RK. VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects. Trends Mol Med 2007;13:223-30. [PMID: 17462954 DOI: 10.1016/j.molmed.2007.04.001] [Cited by in Crossref: 102] [Cited by in F6Publishing: 96] [Article Influence: 6.8] [Reference Citation Analysis]
520 Strilić B, Kucera T, Lammert E. Formation of cardiovascular tubes in invertebrates and vertebrates. Cell Mol Life Sci 2010;67:3209-18. [PMID: 20490602 DOI: 10.1007/s00018-010-0400-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
521 Körbel C, Gerstner MD, Menger MD, Laschke MW. Notch signaling controls sprouting angiogenesis of endometriotic lesions. Angiogenesis 2018;21:37-46. [PMID: 28993956 DOI: 10.1007/s10456-017-9580-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
522 Takano S, Yamashita T, Ohneda O. Molecular therapeutic targets for glioma angiogenesis. J Oncol 2010;2010:351908. [PMID: 20414463 DOI: 10.1155/2010/351908] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
523 Borah A, Raveendran S, Rochani A, Maekawa T, Kumar DS. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis 2015;4:e177. [PMID: 26619402 DOI: 10.1038/oncsis.2015.35] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 13.6] [Reference Citation Analysis]
524 Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov. 2009;8:806-823. [PMID: 19794444 DOI: 10.1038/nrd2137] [Cited by in Crossref: 587] [Cited by in F6Publishing: 558] [Article Influence: 45.2] [Reference Citation Analysis]
525 Koga J, Aikawa M. Application of anti-ligand antibodies to inhibit Notch signaling. Methods Mol Biol 2014;1187:335-42. [PMID: 25053501 DOI: 10.1007/978-1-4939-1139-4_25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
526 Sakurai T, Kudo M. Signaling pathways governing tumor angiogenesis. Oncology. 2011;81 Suppl 1:24-29. [PMID: 22212932 DOI: 10.1159/000333256] [Cited by in Crossref: 113] [Cited by in F6Publishing: 107] [Article Influence: 10.3] [Reference Citation Analysis]
527 Chappell JC, Wiley DM, Bautch VL. How blood vessel networks are made and measured. Cells Tissues Organs 2012;195:94-107. [PMID: 21996655 DOI: 10.1159/000331398] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
528 Pitulescu ME, Schmidt I, Giaimo BD, Antoine T, Berkenfeld F, Ferrante F, Park H, Ehling M, Biljes D, Rocha SF, Langen UH, Stehling M, Nagasawa T, Ferrara N, Borggrefe T, Adams RH. Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. Nat Cell Biol 2017;19:915-27. [DOI: 10.1038/ncb3555] [Cited by in Crossref: 134] [Cited by in F6Publishing: 128] [Article Influence: 26.8] [Reference Citation Analysis]
529 Caliceti C, Aquila G, Pannella M, Morelli MB, Fortini C, Pinton P, Bonora M, Hrelia S, Pannuti A, Miele L, Rizzo P, Ferrari R. 17β-estradiol enhances signalling mediated by VEGF-A-delta-like ligand 4-notch1 axis in human endothelial cells. PLoS One 2013;8:e71440. [PMID: 23967210 DOI: 10.1371/journal.pone.0071440] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
530 Hammond WA, Swaika A, Mody K. Pharmacologic resistance in colorectal cancer: a review. Ther Adv Med Oncol. 2016;8:57-84. [PMID: 26753006 DOI: 10.1177/1758834015614530] [Cited by in Crossref: 203] [Cited by in F6Publishing: 194] [Article Influence: 33.8] [Reference Citation Analysis]
531 Tarrant JM, Lewin-Koh SC, Lewin-Koh N. Development of a safety biomarker signature to detect hepatic sinusoidal dilation associated with an anti-DLL4 biotherapeutic. Biomarkers 2014;19:391-401. [PMID: 24842386 DOI: 10.3109/1354750X.2014.919026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
532 Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D, Chen YC, Honoki K, Fujii H, Georgakilas AG, Nowsheen S, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich B, Yang X, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Halicka D, Mohammed SI, Azmi AS, Bilsland A, Keith WN, Jensen LD. Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 2015;35 Suppl:S224-43. [PMID: 25600295 DOI: 10.1016/j.semcancer.2015.01.001] [Cited by in Crossref: 245] [Cited by in F6Publishing: 225] [Article Influence: 35.0] [Reference Citation Analysis]
533 Murphy PA, Lu G, Shiah S, Bollen AW, Wang RA. Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease. Lab Invest 2009;89:971-82. [PMID: 19546852 DOI: 10.1038/labinvest.2009.62] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
534 Wiseman J, Gregersson P, Johansson J, Magnell K, Pilataxi F, Morehouse C, Brohawn P, Holoweckyj N, Strout P, Cho S. Generation of a functional humanized Delta-like ligand 4 transgenic mouse model. Transgenic Res 2017;26:791-8. [PMID: 28819706 DOI: 10.1007/s11248-017-0040-3] [Reference Citation Analysis]
535 Nijhawans P, Behl T, Bhardwaj S. Angiogenesis in obesity. Biomed Pharmacother 2020;126:110103. [PMID: 32200253 DOI: 10.1016/j.biopha.2020.110103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
536 Hernandez Tejada FN. Galvez Silva JR, Zweidler-McKay PA. The challenge of targeting notch in hematologic malignancies. Front Pediatr. 2014;2:54. [PMID: 24959528 DOI: 10.3389/fped.2014.00054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
537 Tang H, Feng Y, Yao L. Angiogenesis, Vasculogenesis, and Vasculogenic Mimicry in Ovarian Cancer: . International Journal of Gynecological Cancer 2009;19:605-10. [DOI: 10.1111/igc.0b013e3181a389e6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
538 Lino MM, Merlo A, Boulay JL. Notch signaling in glioblastoma: a developmental drug target? BMC Med. 2010;8:72. [PMID: 21078177 DOI: 10.1186/1741-7015-8-72] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
539 Kim PM, Lee JJ, Choi D, Eoh H, Hong YK. Endothelial lineage-specific interaction of Mycobacterium tuberculosis with the blood and lymphatic systems. Tuberculosis (Edinb) 2018;111:1-7. [PMID: 30029892 DOI: 10.1016/j.tube.2018.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
540 Liu SK, Bham SA, Fokas E, Beech J, Im J, Cho S, Harris AL, Muschel RJ. Delta-like ligand 4-notch blockade and tumor radiation response. J Natl Cancer Inst. 2011;103:1778-1798. [PMID: 22010178 DOI: 10.1093/jnci/djr419] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
541 Bazan-peregrino M, Sainson RCA, Carlisle RC, Thoma C, Waters RA, Arvanitis C, Harris AL, Hernandez-alcoceba R, Seymour LW. Combining virotherapy and angiotherapy for the treatment of breast cancer. Cancer Gene Ther 2013;20:461-8. [DOI: 10.1038/cgt.2013.41] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
542 Hirashima M. Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling. Anat Sci Int 2009;84:95-101. [PMID: 19259767 DOI: 10.1007/s12565-009-0026-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
543 Rørth P. Fellow travellers: emergent properties of collective cell migration. EMBO Rep 2012;13:984-91. [PMID: 23059978 DOI: 10.1038/embor.2012.149] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 12.5] [Reference Citation Analysis]
544 Niessen K, Zhang G, Ridgway JB, Chen H, Yan M. ALK1 signaling regulates early postnatal lymphatic vessel development. Blood 2010;115:1654-61. [PMID: 19903896 DOI: 10.1182/blood-2009-07-235655] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
545 Kim Y, Byeon SJ, Hur J, Lee K, Kim D, Ahn JH, Lee SH, You WK, Kim ST, Park SH, Kang WK, Kim KM, Lee J. High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer. J Cancer 2019;10:3172-8. [PMID: 31289587 DOI: 10.7150/jca.30257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
546 Blanco R, Gerhardt H. VEGF and Notch in tip and stalk cell selection. Cold Spring Harb Perspect Med 2013;3:a006569. [PMID: 23085847 DOI: 10.1101/cshperspect.a006569] [Cited by in Crossref: 275] [Cited by in F6Publishing: 252] [Article Influence: 30.6] [Reference Citation Analysis]
547 Monticone G, Miele L. Notch Pathway: A Journey from Notching Phenotypes to Cancer Immunotherapy. Adv Exp Med Biol 2021;1287:201-22. [PMID: 33034034 DOI: 10.1007/978-3-030-55031-8_13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
548 Yan M. Therapeutic promise and challenges of targeting DLL4/NOTCH1. Vasc Cell. 2011;3:17. [PMID: 21824400 DOI: 10.1186/2045-824x-3-17] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
549 Previs RA, Coleman RL, Harris AL, Sood AK. Molecular pathways: translational and therapeutic implications of the Notch signaling pathway in cancer. Clin Cancer Res. 2015;21:955-961. [PMID: 25388163 DOI: 10.1158/1078-0432.ccr-14-0809] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 10.9] [Reference Citation Analysis]
550 Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov. 2014;13:497-512. [PMID: 24981363 DOI: 10.1038/nrd4253] [Cited by in Crossref: 573] [Cited by in F6Publishing: 558] [Article Influence: 71.6] [Reference Citation Analysis]
551 Xia S, Menden HL, Korfhagen TR, Kume T, Sampath V. Endothelial immune activation programmes cell-fate decisions and angiogenesis by inducing angiogenesis regulator DLL4 through TLR4-ERK-FOXC2 signalling. J Physiol 2018;596:1397-417. [PMID: 29380370 DOI: 10.1113/JP275453] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
552 Venkatesh V, Nataraj R, Thangaraj GS, Karthikeyan M, Gnanasekaran A, Kaginelli SB, Kuppanna G, Kallappa CG, Basalingappa KM. Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investig. 2018;5:5. [PMID: 29682512 DOI: 10.21037/sci.2018.02.02] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 27.0] [Reference Citation Analysis]
553 Adam MG, Berger C, Feldner A, Yang WJ, Wüstehube-Lausch J, Herberich SE, Pinder M, Gesierich S, Hammes HP, Augustin HG, Fischer A. Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis. Circ Res 2013;113:1206-18. [PMID: 24025447 DOI: 10.1161/CIRCRESAHA.113.301686] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
554 Carlier A, Geris L, Bentley K, Carmeliet G, Carmeliet P, Van Oosterwyck H. MOSAIC: a multiscale model of osteogenesis and sprouting angiogenesis with lateral inhibition of endothelial cells. PLoS Comput Biol 2012;8:e1002724. [PMID: 23071433 DOI: 10.1371/journal.pcbi.1002724] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
555 Bae YH, Park HJ, Kim SR, Kim JY, Kang Y, Kim JA, Wee HJ, Kageyama R, Jung JS, Bae MK, Bae SK. Notch1 mediates visfatin-induced FGF-2 up-regulation and endothelial angiogenesis. Cardiovasc Res 2011;89:436-45. [PMID: 20817637 DOI: 10.1093/cvr/cvq276] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
556 Zhu Q, Li J, Wu Q, Cheng Y, Zheng H, Zhan T, Wang H, Yang Y, Wang H, Liu Y, Guo S. Linc-OIP5 in the breast cancer cells regulates angiogenesis of human umbilical vein endothelial cells through YAP1/Notch/NRP1 signaling circuit at a tumor microenvironment. Biol Res 2020;53:5. [PMID: 32046779 DOI: 10.1186/s40659-020-0273-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
557 Guarani V, Deflorian G, Franco CA, Krüger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MHH, Zimmermann B, Brandes RP, Mione M, Westphal CH, Braun T, Zeiher AM, Gerhardt H, Dimmeler S, Potente M. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 2011;473:234-8. [PMID: 21499261 DOI: 10.1038/nature09917] [Cited by in Crossref: 257] [Cited by in F6Publishing: 240] [Article Influence: 23.4] [Reference Citation Analysis]
558 Zheng X, Narayanan S, Sunkari VG, Eliasson S, Botusan IR, Grünler J, Catrina AI, Radtke F, Xu C, Zhao A, Ekberg NR, Lendahl U, Catrina SB. Triggering of a Dll4-Notch1 loop impairs wound healing in diabetes. Proc Natl Acad Sci U S A 2019;116:6985-94. [PMID: 30886104 DOI: 10.1073/pnas.1900351116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
559 Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, Liu ZJ. Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Oncogene 2011;30:4316-26. [PMID: 21516124 DOI: 10.1038/onc.2011.142] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
560 Yuen WW, Du NR, Shvartsman D, Arany PR, Lam H, Mooney DJ. Statistical platform to discern spatial and temporal coordination of endothelial sprouting. Integr Biol (Camb) 2012;4:292-300. [PMID: 22318325 DOI: 10.1039/c2ib00057a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
561 Shaw D, Clamp A, Jayson GC. Angiogenesis as a target for the treatment of ovarian cancer. Current Opinion in Oncology 2013;25:558-65. [DOI: 10.1097/cco.0b013e328363e0da] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
562 Kovall RA, Blacklow SC. Mechanistic insights into Notch receptor signaling from structural and biochemical studies. Curr Top Dev Biol 2010;92:31-71. [PMID: 20816392 DOI: 10.1016/S0070-2153(10)92002-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 97] [Article Influence: 11.9] [Reference Citation Analysis]
563 Kwon SM, Alev C, Asahara T. The role of notch signaling in endothelial progenitor cell biology. Trends Cardiovasc Med 2009;19:170-3. [PMID: 20005477 DOI: 10.1016/j.tcm.2009.10.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
564 Al Haj Zen A, Madeddu P. Notch signalling in ischaemia-induced angiogenesis. Biochem Soc Trans 2009;37:1221-7. [PMID: 19909251 DOI: 10.1042/BST0371221] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
565 Thanapprapasr D, Hu W, Sood AK, Coleman RL. Moving beyond VEGF for anti-angiogenesis strategies in gynecologic cancer. Curr Pharm Des 2012;18:2713-9. [PMID: 22390757 DOI: 10.2174/138161212800626201] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
566 Miele L. Rational targeting of Notch signaling in breast cancer. Expert Rev Anticancer Ther 2008;8:1197-202. [PMID: 18699758 DOI: 10.1586/14737140.8.8.1197] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
567 Mizugaki H, Sakakibara-Konishi J, Ikezawa Y, Kikuchi J, Kikuchi E, Oizumi S, Dang TP, Nishimura M. γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer. Br J Cancer 2012;106:1953-9. [PMID: 22596234 DOI: 10.1038/bjc.2012.178] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
568 Du L, Cheng Q, Zheng H, Liu J, Liu L, Chen Q. Targeting stemness of cancer stem cells to fight colorectal cancers. Semin Cancer Biol 2021:S1044-579X(21)00041-9. [PMID: 33631296 DOI: 10.1016/j.semcancer.2021.02.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
569 Masiero M, Li D, Whiteman P, Bentley C, Greig J, Hassanali T, Watts S, Stribbling S, Yates J, Bealing E, Li JL, Chillakuri C, Sheppard D, Serres S, Sarmiento-Soto M, Larkin J, Sibson NR, Handford PA, Harris AL, Banham AH. Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy. Mol Cancer Ther 2019;18:2030-42. [PMID: 31395687 DOI: 10.1158/1535-7163.MCT-18-1176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
570 van Lessen M, Nakayama M, Kato K, Kim JM, Kaibuchi K, Adams RH. Regulation of vascular endothelial growth factor receptor function in angiogenesis by numb and numb-like. Arterioscler Thromb Vasc Biol 2015;35:1815-25. [PMID: 26069237 DOI: 10.1161/ATVBAHA.115.305473] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
571 Evans I. An Overview of VEGF-Mediated Signal Transduction. Methods Mol Biol 2015;1332:91-120. [PMID: 26285748 DOI: 10.1007/978-1-4939-2917-7_7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
572 Real PJ, Ferrando AA. NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. Leukemia 2009;23:1374-7. [PMID: 19357700 DOI: 10.1038/leu.2009.75] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 6.8] [Reference Citation Analysis]
573 Ucuzian AA, Gassman AA, East AT, Greisler HP. Molecular mediators of angiogenesis. J Burn Care Res 2010;31:158-75. [PMID: 20061852 DOI: 10.1097/BCR.0b013e3181c7ed82] [Cited by in Crossref: 206] [Cited by in F6Publishing: 104] [Article Influence: 17.2] [Reference Citation Analysis]
574 Lake RJ, Haynes MK, Dreval K, Bilkis R, Sklar LA, Fan HY. A Novel Flow Cytometric Assay to Identify Inhibitors of RBPJ-DNA Interactions. SLAS Discov 2020;25:895-905. [PMID: 32567455 DOI: 10.1177/2472555220932552] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
575 Dimova I, Hlushchuk R, Makanya A, Styp-rekowska B, Ceausu A, Flueckiger S, Lang S, Semela D, Le Noble F, Chatterjee S, Djonov V. Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cells. Angiogenesis 2013;16:921-37. [DOI: 10.1007/s10456-013-9366-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
576 Rice MA, Hsu EC, Aslan M, Ghoochani A, Su A, Stoyanova T. Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen Therapies. Mol Cancer Ther 2019;18:1230-42. [PMID: 31028097 DOI: 10.1158/1535-7163.MCT-18-0804] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
577 Laschke MW, Vollmar B, Menger MD. Inosculation: connecting the life-sustaining pipelines. Tissue Eng Part B Rev 2009;15:455-65. [PMID: 19552605 DOI: 10.1089/ten.TEB.2009.0252] [Cited by in Crossref: 100] [Cited by in F6Publishing: 80] [Article Influence: 8.3] [Reference Citation Analysis]
578 García-pascual CM, Zimmermann RC, Ferrero H, Shawber CJ, Kitajewski J, Simón C, Pellicer A, Gómez R. Delta-like ligand 4 regulates vascular endothelial growth factor receptor 2–driven luteal angiogenesis through induction of a tip/stalk phenotype in proliferating endothelial cells. Fertility and Sterility 2013;100:1768-1776.e1. [DOI: 10.1016/j.fertnstert.2013.08.034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
579 Tsao PN, Wei SC, Wu MF, Huang MT, Lin HY, Lee MC, Lin KM, Wang IJ, Kaartinen V, Yang LT, Cardoso WV. Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. Development 2011;138:3533-43. [PMID: 21791528 DOI: 10.1242/dev.063727] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
580 Li N, Zhou P, Yang M, Fang X, Krämer N, Mughal TA, Abbasi AA, Yang Y, Kaindl AM, Hu H. Zebrafish modeling mimics developmental phenotype of patients with RAPGEF1 mutation. Clin Genet 2021;100:144-55. [PMID: 33834495 DOI: 10.1111/cge.13965] [Reference Citation Analysis]
581 Ghosh S, Khanam R, Acharya Chowdhury A. The Evolving Roles of Bacopa monnieri as Potential Anti-Cancer Agent: A Review. Nutr Cancer 2020;:1-11. [PMID: 33148034 DOI: 10.1080/01635581.2020.1841248] [Reference Citation Analysis]
582 Wang J, Liu Q, Gao H, Wan D, Li C, Li Z, Zhang Y. EGFL7 participates in regulating biological behavior of growth hormone–secreting pituitary adenomas via Notch2/DLL3 signaling pathway. Tumour Biol 2017;39:101042831770620. [DOI: 10.1177/1010428317706203] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
583 Fraser HM, Hastings JM, Allan D, Morris KD, Rudge JS, Wiegand SJ. Inhibition of delta-like ligand 4 induces luteal hypervascularization followed by functional and structural luteolysis in the primate ovary. Endocrinology 2012;153:1972-83. [PMID: 22334711 DOI: 10.1210/en.2011-1688] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
584 Mayor R, Etienne-Manneville S. The front and rear of collective cell migration. Nat Rev Mol Cell Biol 2016;17:97-109. [PMID: 26726037 DOI: 10.1038/nrm.2015.14] [Cited by in Crossref: 396] [Cited by in F6Publishing: 329] [Article Influence: 66.0] [Reference Citation Analysis]
585 Mesri EA, Cesarman E. Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D. Cell Host Microbe 2011;10:529-31. [PMID: 22177556 DOI: 10.1016/j.chom.2011.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
586 Brastianos PK, Batchelor TT. Vascular endothelial growth factor inhibitors in malignant gliomas. Target Oncol 2010;5:167-74. [PMID: 20821351 DOI: 10.1007/s11523-010-0158-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
587 Hayashi H, Sano H, Seo S, Kume T. The Foxc2 transcription factor regulates angiogenesis via induction of integrin beta3 expression. J Biol Chem 2008;283:23791-800. [PMID: 18579532 DOI: 10.1074/jbc.M800190200] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
588 Sjölund J, Johansson M, Manna S, Norin C, Pietras A, Beckman S, Nilsson E, Ljungberg B, Axelson H. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest 2008;118:217-28. [PMID: 18079963 DOI: 10.1172/JCI32086] [Cited by in Crossref: 134] [Cited by in F6Publishing: 79] [Article Influence: 9.6] [Reference Citation Analysis]
589 Mao R, Meng S, Gu Q, Araujo-Gutierrez R, Kumar S, Yan Q, Almazan F, Youker KA, Fu Y, Pownall HJ, Cooke JP, Miller YI, Fang L. AIBP Limits Angiogenesis Through γ-Secretase-Mediated Upregulation of Notch Signaling. Circ Res 2017;120:1727-39. [PMID: 28325782 DOI: 10.1161/CIRCRESAHA.116.309754] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
590 Sainson RC, Harris AL. Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis? Trends Mol Med. 2007;13:389-395. [PMID: 17822956 DOI: 10.1016/j.molmed.2007.07.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
591 O'Neill CF, Urs S, Cinelli C, Lincoln A, Nadeau RJ, León R, Toher J, Mouta-Bellum C, Friesel RE, Liaw L. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am J Pathol. 2007;171:1023-1036. [PMID: 17675579 DOI: 10.2353/ajpath.2007.061029] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 5.5] [Reference Citation Analysis]
592 Siekmann AF, Covassin L, Lawson ND. Modulation of VEGF signalling output by the Notch pathway. Bioessays. 2008;30:303-313. [PMID: 18348190 DOI: 10.1002/bies.20736] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 8.4] [Reference Citation Analysis]
593 Eilken HM, Adams RH. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol. 2010;22:617-625. [PMID: 20817428 DOI: 10.1016/j.ceb.2010.08.010] [Cited by in Crossref: 331] [Cited by in F6Publishing: 310] [Article Influence: 30.1] [Reference Citation Analysis]
594 Quillard T, Charreau B. Impact of notch signaling on inflammatory responses in cardiovascular disorders. Int J Mol Sci 2013;14:6863-88. [PMID: 23531541 DOI: 10.3390/ijms14046863] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
595 Caolo V, Molin DG, Post MJ. Notch regulation of hematopoiesis, endothelial precursor cells, and blood vessel formation: orchestrating the vasculature. Stem Cells Int 2012;2012:805602. [PMID: 22550518 DOI: 10.1155/2012/805602] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
596 Niessen K, Zhang G, Ridgway JB, Chen H, Kolumam G, Siebel CW, Yan M. The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development. Blood 2011;118:1989-97. [PMID: 21700774 DOI: 10.1182/blood-2010-11-319129] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 6.4] [Reference Citation Analysis]
597 Ojala PM, Schulz TF. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation. Semin Cancer Biol 2014;26:69-77. [PMID: 24486643 DOI: 10.1016/j.semcancer.2014.01.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
598 Shiraha H, Nishina S, Yamamoto K. Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma. J Cell Biochem 2011;112:745-9. [PMID: 21328447 DOI: 10.1002/jcb.22973] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
599 Yartseva V, Goldstein LD, Rodman J, Kates L, Chen MZ, Chen YJ, Foreman O, Siebel CW, Modrusan Z, Peterson AS, Jovičić A. Heterogeneity of Satellite Cells Implicates DELTA1/NOTCH2 Signaling in Self-Renewal. Cell Rep 2020;30:1491-1503.e6. [PMID: 32023464 DOI: 10.1016/j.celrep.2019.12.100] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
600 Rodrigues MFSD, Miguita L, De Andrade NP, Heguedusch D, Rodini CO, Moyses RA, Toporcov TN, Gama RR, Tajara EE, Nunes FD. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma. Int J Oncol 2018;53:2458-72. [PMID: 30272273 DOI: 10.3892/ijo.2018.4572] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
601 Wu Q, Huang Y. The role of DLL1 in long-term vascular normalization and cancer immunotherapy. Cancer Biol Med 2021:j. [PMID: 34708998 DOI: 10.20892/j.issn.2095-3941.2021.0507] [Reference Citation Analysis]
602 Stockmann C, Schadendorf D, Klose R, Helfrich I. The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol 2014;4:69. [PMID: 24782982 DOI: 10.3389/fonc.2014.00069] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 11.1] [Reference Citation Analysis]
603 Balistreri CR, Madonna R, Melino G, Caruso C. The emerging role of Notch pathway in ageing: Focus on the related mechanisms in age-related diseases. Ageing Research Reviews 2016;29:50-65. [DOI: 10.1016/j.arr.2016.06.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
604 Sewell F, Chapman K, Couch J, Dempster M, Heidel S, Loberg L, Maier C, Maclachlan TK, Todd M, van der Laan JW. Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use. MAbs 2017;9:742-55. [PMID: 28475417 DOI: 10.1080/19420862.2017.1324376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
605 Stockhausen MT, Kristoffersen K, Poulsen HS. Notch signaling and brain tumors. Adv Exp Med Biol 2012;727:289-304. [PMID: 22399356 DOI: 10.1007/978-1-4614-0899-4_22] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
606 Siekmann AF, Affolter M, Belting HG. The tip cell concept 10 years after: new players tune in for a common theme. Exp Cell Res 2013;319:1255-63. [PMID: 23419245 DOI: 10.1016/j.yexcr.2013.01.019] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
607 Vitorino P, Yeung S, Crow A, Bakke J, Smyczek T, West K, McNamara E, Eastham-Anderson J, Gould S, Harris SF, Ndubaku C, Ye W. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility. Nature 2015;519:425-30. [PMID: 25799996 DOI: 10.1038/nature14323] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 10.6] [Reference Citation Analysis]
608 Kofler NM, Shawber CJ, Kangsamaksin T, Reed HO, Galatioto J, Kitajewski J. Notch signaling in developmental and tumor angiogenesis. Genes Cancer 2011;2:1106-16. [PMID: 22866202 DOI: 10.1177/1947601911423030] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 8.9] [Reference Citation Analysis]
609 Yang H, Li Y, Li T, Xu M, Chen Y, Wu C, Dang X, Liu Y. Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancer. Sci Rep 2014;4:7072. [PMID: 25400232 DOI: 10.1038/srep07072] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
610 Gu Y, Masiero M, Banham AH. Notch signaling: its roles and therapeutic potential in hematological malignancies. Oncotarget 2016;7:29804-23. [PMID: 26934331 DOI: 10.18632/oncotarget.7772] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
611 Real C, Remédio L, Caiado F, Igreja C, Borges C, Trindade A, Pinto-do-Ó P, Yagita H, Duarte A, Dias S. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis. PLoS One 2011;6:e18323. [PMID: 21483741 DOI: 10.1371/journal.pone.0018323] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
612 Geudens I, Gerhardt H. Coordinating cell behaviour during blood vessel formation. Development 2011;138:4569-83. [PMID: 21965610 DOI: 10.1242/dev.062323] [Cited by in Crossref: 233] [Cited by in F6Publishing: 212] [Article Influence: 21.2] [Reference Citation Analysis]
613 Rahman S, Patel YM, Wijelath ES, Sobel MS. Therapeutic potential of novel modulators of neovascularization. Future Cardiol 2008;4:409-26. [PMID: 19804321 DOI: 10.2217/14796678.4.4.409] [Reference Citation Analysis]
614 Liu X, Luo Q, Zheng Y, Liu X, Hu Y, Wang F, Zou L. The role of Delta-like 4 ligand/Notch-ephrin-B2 cascade in the pathogenesis of preeclampsia by regulating functions of endothelial progenitor cell. Placenta 2015;36:1002-10. [DOI: 10.1016/j.placenta.2015.07.123] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
615 Mendonça L, Trindade A, Carvalho C, Correia J, Badenes M, Gigante J, Duarte A. Metastasis is impaired by endothelial-specific Dll4 loss-of-function through inhibition of epithelial-to-mesenchymal transition and reduction of cancer stem cells and circulating tumor cells. Clin Exp Metastasis 2019;36:365-80. [PMID: 31119445 DOI: 10.1007/s10585-019-09973-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
616 Merk H, Zhang S, Lehr T, Müller C, Ulrich M, Bibb JA, Adams RH, Bracher F, Zahler S, Vollmar AM, Liebl J. Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis. Oncotarget 2016;7:6088-104. [PMID: 26755662 DOI: 10.18632/oncotarget.6842] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
617 Blei F. Literature watch. Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. Lymphat Res Biol 2007;5:49-65. [PMID: 17508902 DOI: 10.1089/lrb.2007.5106] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
618 Lin FJ, Qin J, Tang K, Tsai SY, Tsai MJ. Coup d'Etat: an orphan takes control. Endocr Rev 2011;32:404-21. [PMID: 21257780 DOI: 10.1210/er.2010-0021] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 8.7] [Reference Citation Analysis]
619 Luo D, Zhang X, Du R, Gao W, Luo N, Zhao S, Li Y, Chen R, Wang H, Bao Y, Yang W, Liu D, Shen W. Low dosage of arsenic trioxide (As2O3) inhibits angiogenesis in epithelial ovarian cancer without cell apoptosis. J Biol Inorg Chem 2018;23:939-47. [DOI: 10.1007/s00775-018-1595-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
620 Zanotti S, Canalis E. Notch Signaling and the Skeleton. Endocr Rev. 2016;37:223-253. [PMID: 27074349 DOI: 10.1210/er.2016-1002] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 18.7] [Reference Citation Analysis]
621 Chen BJ, Tang YJ, Tang YL, Liang XH. What makes cells move: Requirements and obstacles for leader cells in collective invasion. Exp Cell Res 2019;382:111481. [PMID: 31247191 DOI: 10.1016/j.yexcr.2019.06.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
622 Wu K, Zhang L, Lin Y, Yang K, Cheng Y. Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in renal cell carcinoma. Oncol Lett 2014;8:55-61. [PMID: 24959218 DOI: 10.3892/ol.2014.2078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
623 Falcon BL, Stewart J, Ezell S, Hanson J, Wijsman J, Ye X, Westin E, Donoho G, Credille K, Uhlik MT. High-content multiplexed tissue imaging and quantification for cancer drug discovery. Drug Discovery Today 2013;18:510-22. [DOI: 10.1016/j.drudis.2012.08.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
624 Isherwood BJ, Walls RE, Roberts ME, Houslay TM, Brave SR, Barry ST, Carragher NO. High-content analysis to leverage a robust phenotypic profiling approach to vascular modulation. J Biomol Screen 2013;18:1246-59. [PMID: 24108119 DOI: 10.1177/1087057113499775] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
625 McManus MM, Weiss KR, Hughes DP. Understanding the role of Notch in osteosarcoma. Adv Exp Med Biol 2014;804:67-92. [PMID: 24924169 DOI: 10.1007/978-3-319-04843-7_4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
626 Scheppke L, Murphy EA, Zarpellon A, Hofmann JJ, Merkulova A, Shields DJ, Weis SM, Byzova TV, Ruggeri ZM, Iruela-Arispe ML, Cheresh DA. Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood 2012;119:2149-58. [PMID: 22134168 DOI: 10.1182/blood-2011-04-348706] [Cited by in Crossref: 91] [Cited by in F6Publishing: 90] [Article Influence: 8.3] [Reference Citation Analysis]
627 Miwa D, Sakaue T, Inoue H, Takemori N, Kurokawa M, Fukuda S, Omi K, Goishi K, Higashiyama S. Protein kinase D2 and heat shock protein 90 beta are required for BCL6-associated zinc finger protein mRNA stabilization induced by vascular endothelial growth factor-A. Angiogenesis 2013;16:675-88. [DOI: 10.1007/s10456-013-9345-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
628 Ding Z, Zu S, Gu J. Evaluating the molecule-based prediction of clinical drug responses in cancer. Bioinformatics 2016;32:2891-5. [DOI: 10.1093/bioinformatics/btw344] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
629 Leslie JD, Ariza-McNaughton L, Bermange AL, McAdow R, Johnson SL, Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 2007;134:839-44. [PMID: 17251261 DOI: 10.1242/dev.003244] [Cited by in Crossref: 296] [Cited by in F6Publishing: 273] [Article Influence: 19.7] [Reference Citation Analysis]
630 Rooney P, Connolly M, Gao W, McCormick J, Biniecka M, Sullivan O, Kirby B, Sweeney C, Molloy E, Markham T, Fearon U, Veale DJ. Notch-1 mediates endothelial cell activation and invasion in psoriasis. Exp Dermatol 2014;23:113-8. [PMID: 24330353 DOI: 10.1111/exd.12306] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
631 Cao L, Arany PR, Wang YS, Mooney DJ. Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. Biomaterials 2009;30:4085-93. [PMID: 19481797 DOI: 10.1016/j.biomaterials.2009.04.051] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
632 Yamanda S, Ebihara S, Asada M, Okazaki T, Niu K, Ebihara T, Koyanagi A, Yamaguchi N, Yagita H, Arai H. Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade. Blood 2009;113:3631-9. [DOI: 10.1182/blood-2008-07-170381] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
633 Campbell KT, Hadley DJ, Kukis DL, Silva EA. Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications. PLoS One 2017;12:e0181484. [PMID: 28723974 DOI: 10.1371/journal.pone.0181484] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 6.6] [Reference Citation Analysis]
634 Salvucci O, Tosato G. Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res 2012;114:21-57. [PMID: 22588055 DOI: 10.1016/B978-0-12-386503-8.00002-8] [Cited by in Crossref: 84] [Cited by in F6Publishing: 51] [Article Influence: 8.4] [Reference Citation Analysis]
635 Xu J, Vilanova G, Gomez H. A Mathematical Model Coupling Tumor Growth and Angiogenesis. PLoS One 2016;11:e0149422. [PMID: 26891163 DOI: 10.1371/journal.pone.0149422] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
636 Benedito R, Roca C, Sörensen I, Adams S, Gossler A, Fruttiger M, Adams RH. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 2009;137:1124-35. [PMID: 19524514 DOI: 10.1016/j.cell.2009.03.025] [Cited by in Crossref: 665] [Cited by in F6Publishing: 631] [Article Influence: 51.2] [Reference Citation Analysis]
637 Kalén M, Wallgard E, Asker N, Nasevicius A, Athley E, Billgren E, Larson JD, Wadman SA, Norseng E, Clark KJ, He L, Karlsson-Lindahl L, Häger AK, Weber H, Augustin H, Samuelsson T, Kemmet CK, Utesch CM, Essner JJ, Hackett PB, Hellström M. Combination of reverse and chemical genetic screens reveals angiogenesis inhibitors and targets. Chem Biol 2009;16:432-41. [PMID: 19389629 DOI: 10.1016/j.chembiol.2009.02.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
638 Wong MS, Sidik SM, Mahmud R, Stanslas J. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects. Clin Exp Pharmacol Physiol 2013;40:307-19. [PMID: 23534409 DOI: 10.1111/1440-1681.12083] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
639 Stremitzer S, Zhang W, Yang D, Ning Y, Stintzing S, Sunakawa Y, Sebio A, Yamauchi S, Matsusaka S, Parekh A, Barzi A, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ. Variations in genes involved in dormancy associated with outcome in patients with resected colorectal liver metastases. Ann Oncol 2015;26:1728-33. [PMID: 25957329 DOI: 10.1093/annonc/mdv224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
640 Kanada M, Zhang J, Yan L, Sakurai T, Terakawa S. Endothelial cell-initiated extravasation of cancer cells visualized in zebrafish. PeerJ 2014;2:e688. [PMID: 25551022 DOI: 10.7717/peerj.688] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
641 Allen F, Maillard I. Therapeutic Targeting of Notch Signaling: From Cancer to Inflammatory Disorders. Front Cell Dev Biol 2021;9:649205. [PMID: 34124039 DOI: 10.3389/fcell.2021.649205] [Reference Citation Analysis]
642 Zhu D, Wang Y, Zou C, She X, Zheng Z. The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway. Biochemical and Biophysical Research Communications 2018;503:921-9. [DOI: 10.1016/j.bbrc.2018.06.097] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
643 Demarest SJ, Hariharan K, Dong J. Emerging antibody combinations in oncology. MAbs 2011;3:338-51. [PMID: 21697653 DOI: 10.4161/mabs.3.4.16615] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
644 Zhou R, Wang S, Wen H, Wang M, Wu M. The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models. Experimental Cell Research 2019;380:141-8. [DOI: 10.1016/j.yexcr.2019.04.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
645 Huang MT, Chiu CJ, Chiang BL. Multi-Faceted Notch in Allergic Airway Inflammation. Int J Mol Sci 2019;20:E3508. [PMID: 31319491 DOI: 10.3390/ijms20143508] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
646 Surendran S, S Ramegowda K, Suresh A, Binil Raj SS, Lakkappa RK, Kamalapurkar G, Radhakrishnan N, C Kartha C. Arterialization and anomalous vein wall remodeling in varicose veins is associated with upregulated FoxC2-Dll4 pathway. Lab Invest 2016;96:399-408. [PMID: 26808710 DOI: 10.1038/labinvest.2015.167] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
647 Jovanovic VP, Sauer CM, Shawber CJ, Gomez R, Wang X, Sauer MV, Kitajewski J, Zimmermann RC. Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dll4). Reprod Biol Endocrinol 2013;11:43. [PMID: 23675950 DOI: 10.1186/1477-7827-11-43] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
648 Plentz R, Park JS, Rhim AD, Abravanel D, Hezel AF, Sharma SV, Gurumurthy S, Deshpande V, Kenific C, Settleman J. Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology. 2009;136:1741-9.e6. [PMID: 19208345 DOI: 10.1053/j.gastro.2009.01.008] [Cited by in Crossref: 110] [Cited by in F6Publishing: 107] [Article Influence: 8.5] [Reference Citation Analysis]
649 Fink AF, Ciliberti G, Popp R, Sirait-Fischer E, Frank AC, Fleming I, Sekar D, Weigert A, Brüne B. IL27Rα Deficiency Alters Endothelial Cell Function and Subverts Tumor Angiogenesis in Mammary Carcinoma. Front Oncol 2019;9:1022. [PMID: 31637217 DOI: 10.3389/fonc.2019.01022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
650 Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, Waltari M, Hellström M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Ylä-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C, Alitalo K. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008;454:656-60. [PMID: 18594512 DOI: 10.1038/nature07083] [Cited by in Crossref: 568] [Cited by in F6Publishing: 542] [Article Influence: 40.6] [Reference Citation Analysis]
651 Yin L, Velazquez OC, Liu ZJ. Notch signaling: emerging molecular targets for cancer therapy. Biochem Pharmacol. 2010;80:690-701. [PMID: 20361945 DOI: 10.1016/j.bcp.2010.03.026] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 9.7] [Reference Citation Analysis]
652 Palm MM, Dallinga MG, van Dijk E, Klaassen I, Schlingemann RO, Merks RM. Computational Screening of Tip and Stalk Cell Behavior Proposes a Role for Apelin Signaling in Sprout Progression. PLoS One 2016;11:e0159478. [PMID: 27828952 DOI: 10.1371/journal.pone.0159478] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
653 He W, Luistro L, Carvajal D, Smith M, Nevins T, Yin X, Cai J, Higgins B, Kolinsky K, Rizzo C, Packman K, Heimbrook D, Boylan JF. High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097. Mol Oncol 2011;5:292-301. [PMID: 21315665 DOI: 10.1016/j.molonc.2011.01.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
654 Ballhause TM, Jiang S, Baranowsky A, Brandt S, Mertens PR, Frosch KH, Yorgan T, Keller J. Relevance of Notch Signaling for Bone Metabolism and Regeneration. Int J Mol Sci 2021;22:1325. [PMID: 33572704 DOI: 10.3390/ijms22031325] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
655 Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, He X, Hervey-Jumper SL, Heth JA, Muraszko KM. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res. 2011;71:6061-6072. [PMID: 21788346 DOI: 10.1158/0008-5472.can-10-4269] [Cited by in Crossref: 230] [Cited by in F6Publishing: 147] [Article Influence: 20.9] [Reference Citation Analysis]
656 Kerr G, Sheldon H, Chaikuad A, Alfano I, von Delft F, Bullock AN, Harris AL. A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis. Angiogenesis 2015;18:209-17. [PMID: 25557927 DOI: 10.1007/s10456-014-9457-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
657 Zheng W, Aspelund A, Alitalo K. Lymphangiogenic factors, mechanisms, and applications. J Clin Invest. 2014;124:878-887. [PMID: 24590272 DOI: 10.1172/jci71603] [Cited by in Crossref: 188] [Cited by in F6Publishing: 123] [Article Influence: 23.5] [Reference Citation Analysis]
658 Oon CE, Bridges E, Sheldon H, Sainson RCA, Jubb A, Turley H, Leek R, Buffa F, Harris AL, Li JL. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth. Oncotarget 2017;8:40115-31. [PMID: 28445154 DOI: 10.18632/oncotarget.16969] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
659 Kwon SM, Eguchi M, Wada M, Iwami Y, Hozumi K, Iwaguro H, Masuda H, Kawamoto A, Asahara T. Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation 2008;118:157-65. [PMID: 18591437 DOI: 10.1161/CIRCULATIONAHA.107.754978] [Cited by in Crossref: 95] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
660 Payne LB, Darden J, Suarez-Martinez AD, Zhao H, Hendricks A, Hartland C, Chong D, Kushner EJ, Murfee WL, Chappell JC. Pericyte migration and proliferation are tightly synchronized to endothelial cell sprouting dynamics. Integr Biol (Camb) 2021;13:31-43. [PMID: 33515222 DOI: 10.1093/intbio/zyaa027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
661 Li D, Xie K, Ding G, Li J, Chen K, Li H, Qian J, Jiang C, Fang J. Tumor resistance to anti-VEGF therapy through up-regulation of VEGF-C expression. Cancer Lett 2014;346:45-52. [PMID: 24333721 DOI: 10.1016/j.canlet.2013.12.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
662 Fung E, Tang ST, Canner JP, Morishige K, Arboleda-velasquez JF, Cardoso AA, Carlesso N, Aster JC, Aikawa M. Delta-Like 4 Induces Notch Signaling in Macrophages: Implications for Inflammation. Circulation 2007;115:2948-56. [DOI: 10.1161/circulationaha.106.675462] [Cited by in Crossref: 152] [Cited by in F6Publishing: 92] [Article Influence: 10.1] [Reference Citation Analysis]
663 Holopainen T, Bry M, Alitalo K, Saaristo A. Perspectives on lymphangiogenesis and angiogenesis in cancer: Vascular Biology of Cancer. J Surg Oncol 2011;103:484-8. [DOI: 10.1002/jso.21808] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
664 Boardman R, Pang V, Malhi N, Lynch AP, Leach L, Benest AV, Bates DO, Machado MJC. Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway. Am J Physiol Heart Circ Physiol 2019;316:H1065-75. [PMID: 30681366 DOI: 10.1152/ajpheart.00610.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
665 Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97-106. [PMID: 21151206 DOI: 10.1038/nrclinonc.2010.196] [Cited by in Crossref: 656] [Cited by in F6Publishing: 607] [Article Influence: 54.7] [Reference Citation Analysis]